Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Gene Fusion"" wg kryterium: Temat


Tytuł:
Genetic Characterization of Avian Paramyxovirus Isolated from Wild Waterfowl in Korea between 2015 and 2021.
Autorzy:
Lee, Yea-Jin (AUTHOR)
Park, Jong-Yeol (AUTHOR)
Shang, Ke (AUTHOR)
Zhang, Jun-Feng (AUTHOR)
Choi, Yu-Ri (AUTHOR)
Kim, Sang-Won (AUTHOR)
Cha, Se-Yeoun (AUTHOR)
Kang, Min (AUTHOR)
Wei, Bai (AUTHOR)
Jang, Hyung-Kwan (AUTHOR)
Pokaż więcej
Źródło:
Animals (2076-2615). Mar2024, Vol. 14 Issue 5, p780. 12p.
Czasopismo naukowe
Tytuł:
Identification of Novel/Rare EWSR1 Fusion Partners in Undifferentiated Mesenchymal Neoplasms.
Autorzy:
Salguero-Aranda, Carmen (AUTHOR)
Di Blasi, Elena (AUTHOR)
Galán, Lourdes (AUTHOR)
Zaldumbide, Laura (AUTHOR)
Civantos, Gema (AUTHOR)
Marcilla, David (AUTHOR)
de Álava, Enrique (AUTHOR)
Díaz-Martín, Juan (AUTHOR)
Pokaż więcej
Źródło:
International Journal of Molecular Sciences. Feb2024, Vol. 25 Issue 3, p1735. 16p.
Czasopismo naukowe
Tytuł:
A novel SREBF1::NACC1 gene fusion in an unclassifiable intracranial tumour.
Autorzy:
Takeuchi Y; Department of Diagnostic Pathology, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Clinical Bioresource Center, Kyoto University Hospital, Kyoto, Japan.
Mineharu Y; Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Arakawa Y; Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Hara M; Department of Diagnostic Pathology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Oichi Y; Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kamata T; Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Fukuyama K; Department of Clinical Oncology, Kyoto University Hospital, Kyoto, Japan.
Yamamoto Y; Department of Clinical Oncology, Kyoto University Hospital, Kyoto, Japan.
Yamanaka T; Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
Kakiuchi N; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
Hiratomo E; Department of Diagnostic Pathology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Hirata M; Department of Diagnostic Pathology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Yokoo H; Department of Human Pathology, Gunma University Graduate School of Medicine, Maebashi, Japan.
Hirose T; Department of Diagnostic Pathology, Hyogo Cancer Center, Akashi, Japan.
Minamiguchi S; Department of Diagnostic Pathology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Ogawa S; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
Muto M; Clinical Bioresource Center, Kyoto University Hospital, Kyoto, Japan.; Department of Clinical Oncology, Kyoto University Hospital, Kyoto, Japan.
Miyamoto S; Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Haga H; Department of Diagnostic Pathology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Pokaż więcej
Źródło:
Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2022 Dec; Vol. 48 (7), pp. e12843. Date of Electronic Publication: 2022 Aug 17.
Typ publikacji:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Fusion*
Brain Neoplasms*
Male ; Humans ; Adult ; Sterol Regulatory Element Binding Protein 1 ; Neoplasm Proteins ; Repressor Proteins
Czasopismo naukowe
Tytuł:
CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors.
Autorzy:
Barresi, Valeria (AUTHOR)
Cardoni, Antonello (AUTHOR)
Miele, Evelina (AUTHOR)
Pedace, Lucia (AUTHOR)
Masotto, Barbara (AUTHOR)
Nardini, Claudia (AUTHOR)
Barresi, Sabina (AUTHOR)
Rossi, Sabrina (AUTHOR)
Pokaż więcej
Źródło:
Acta Neuropathologica Communications. 1/12/2024, Vol. 12 Issue 1, p1-7. 7p.
Czasopismo naukowe
Tytuł:
Multiple Genomic Alterations, Including a Novel AFF4::IRF1 Fusion Gene, in a Treatment-Refractory Blastic Plasmacytoid Dendritic-Cell Neoplasm: A Case Report and Literature Review.
Autorzy:
Sahin, Yavuz (AUTHOR)
Wang, Y. Lynn (AUTHOR)
Pei, Jianming (AUTHOR)
Mansoor, Nashwa (AUTHOR)
Styler, Michael (AUTHOR)
Testa, Joseph R. (AUTHOR)
Nejati, Reza (AUTHOR)
Pokaż więcej
Źródło:
International Journal of Molecular Sciences. Jan2024, Vol. 25 Issue 1, p305. 9p.
Czasopismo naukowe
Tytuł:
A Rare Case of Nasal Sarcoma with BCOR Internal Tandem Duplication Showing Complete Pathologic Response to the VDC-IE Chemotherapy Protocol.
Autorzy:
Salah, Samer (AUTHOR)
Sughayer, Maher A. (AUTHOR)
Jaber, Omar (AUTHOR)
Abu Abed, Nebras (AUTHOR)
Ajlouni, Fatena (AUTHOR)
Al Gargaz, Wisam (AUTHOR)
Abu Hijlih, Ramiz (AUTHOR)
Abuhijla, Fawzi (AUTHOR)
Al-Ibraheem, Akram (AUTHOR)
Alul, Farah (AUTHOR)
Naser, Walid (AUTHOR)
Pokaż więcej
Źródło:
Case Reports in Oncological Medicine. 12/26/2023, p1-7. 7p.
Czasopismo naukowe
Tytuł:
Detection of NTRK fusions by RNA-based nCounter is a feasible diagnostic methodology in a real-world scenario for non-small cell lung cancer assessment.
Autorzy:
de Oliveira Cavagna, Rodrigo (AUTHOR)
de Andrade, Edilene Santos (AUTHOR)
Tadin Reis, Monise (AUTHOR)
de Paula, Flávia Escremim (AUTHOR)
Noriz Berardinelli, Gustavo (AUTHOR)
Bonatelli, Murilo (AUTHOR)
Ramos Teixeira, Gustavo (AUTHOR)
Garbe Zaniolo, Beatriz (AUTHOR)
Mourão Dias, Josiane (AUTHOR)
da Silva, Flávio Augusto Ferreira (AUTHOR)
Baston Silva, Carlos Eduardo (AUTHOR)
Xavier Reis, Marina (AUTHOR)
Lopes Maia, Erika (AUTHOR)
de Alencar, Thainara Santos (AUTHOR)
Jacinto, Alexandre Arthur (AUTHOR)
da Nóbrega Oliveira, Rachid Eduardo Noleto (AUTHOR)
Molina-Vila, Miguel A. (AUTHOR)
Ferro Leal, Letícia (AUTHOR)
Reis, Rui Manuel (AUTHOR)
Pokaż więcej
Źródło:
Scientific Reports. 11/30/2023, Vol. 13 Issue 1, p1-10. 10p.
Czasopismo naukowe
Tytuł:
Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China.
Autorzy:
Pu X; The Second Department of Thoracic Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Central South University, Changsha, People's Republic of China.
Xu C; Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, People's Republic of China.; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Wang Q; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, People's Republic of China.
Wang W; Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, People's Republic of China.
Wu F; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Cai X; Department of VIP Inpatient, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Song Z; Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, People's Republic of China.
Yu J; Department of Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Zhong W; Guangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, People's Republic of China.
Wang Z; State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Zhang Y; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
Liu J; Department of Thoracic Cancer, Jilin Cancer Hospital, Jilin, People's Republic of China.
Zhang S; Translational Medicine Research Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Liu A; Department of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Li W; Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Cancer Center, Zhejiang University, Hangzhou, People's Republic of China.
Zhan P; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Liu H; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Lv T; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Miao L; Department of Respiratory Medicine, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Min L; Department of Respiratory Medicine, Clinical Medical School of Yangzhou University, Subei People's Hospital of Jiangsu Province, Yangzhou, People's Republic of China.
Lin G; Department of Medical Oncology, Fujian Medical University Cancer Hospital & Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Huang L; Department of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Yuan J; Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Jiang Z; Department of Integrative Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Rao C; Department of Radiotherapy and Chemotherapy, Hwamei Hospital, University of Chinese Academy of Sciences, Ningbo, People's Republic of China.
Lv D; Department of Pulmonary Medicine, Taizhou Hospital of Wenzhou Medical University, Taizhou, People's Republic of China.
Yu Z; Department of Respiratory Medicine, the 900th Hospital of the Joint Logistics Team (the Former Fuzhou General Hospital), Fujian Medical University, Fuzhou, People's Republic of China.
Li X; Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.
Tang C; Department of Medical Oncology, Peking University International Hospital, Beijing, People's Republic of China.
Zhou C; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease; Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University (The First Affiliated Hospital of Guangzhou Medical University), Guangzhou, People's Republic of China.
Zhang J; Department of Thoracic Oncology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, People's Republic of China.
Guo H; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Chu Q; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Meng R; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Liu X; Department of Oncology, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Wu J; Department of Medical Oncology, the First Affiliated Hospital of Medicine, Xiamen University, Xiamen, People's Republic of China.
Zhou J; Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology, Chengdu, People's Republic of China.
Zhu Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Pan W; Department of Cell Biology, College of Medicine, Jiaxing University, Jiaxing, People's Republic of China.
Pang F; Department of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, People's Republic of China.
Huang J; Department of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, People's Republic of China.
Wang K; Department of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, People's Republic of China.
Wu F; Department of Medical, Menarini Silicon Biosystems Spa, Shanghai, People's Republic of China.
Shen T; Department of Medical, Stone Pharmaceuticals (Suzhou) Co., Ltd., Shanghai, People's Republic of China.
Zou S; Department of Medical, Stone Pharmaceuticals (Suzhou) Co., Ltd., Shanghai, People's Republic of China.
Xu B; Department of Biotherapy, Cancer Institute, First Affiliated Hospital of China Medical University, Shenyang, People's Republic of China.
Wang L; Department of Oncology, Baotou Cancer Hospital, Baotou, People's Republic of China.
Zhu Y; Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxing, People's Republic of China.
Lin X; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease; Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University (The First Affiliated Hospital of Guangzhou Medical University), Guangzhou, People's Republic of China.
Cai J; Department of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Xu L; Department of Interventional Pulmonary Diseases, Anhui Chest Hospital, Hefei, People's Republic of China.
Li J; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinnan, People's Republic of China.
Jiao X; Department of Medical Oncology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.
Li K; Department of Oncology, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.
Feng H; Department of Thoracic Oncology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, People's Republic of China.
Wang L; Department of Pathology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, People's Republic of China.
Du Y; Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.
Yao W; Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
Shi X; Department of Respiratory Medicine, Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, People's Republic of China.
Niu X; Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Yuan D; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Yao Y; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Kang J; Guangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, People's Republic of China.
Zhang J; Guangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, People's Republic of China.
Zhang C; Guangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, People's Republic of China.
Fu J; Department of Medical Oncology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, People's Republic of China.
Huang J; Department of Oncology, Lishui Municipal Central Hospital, Lishui, People's Republic of China.
Zhang Y; Department of Oncology, the Second Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, People's Republic of China.
Sun P; Department of Pathology, The Second Hospital of Jilin University, Changchun, People's Republic of China.
Wang H; Senior Department of Oncology, The 5th Medical Center of PLA General Hospital, Beijing, People's Republic of China.
Ye M; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Wang D; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Wang Z; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Hao Y; Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, People's Republic of China.
Wang Z; Department of Radiation Oncology, Affiliated Jinling Hospital, Medical School of Nanjing, Nanjing, People's Republic of China.
Wan B; Department of Respiratory Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Lv D; Department of Clinical Oncology, The 901 Hospital of Joint Logistics Support Force of People Liberation Army, Hefei, People's Republic of China.
Lan G; Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxing, People's Republic of China.
Yang S; Department of Thoracic Surgery, Chuxiong Yi Autonomous Prefecture People's Hospital, Chuxiong, People's Republic of China.
Shi L; Department of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Wang Y; Department of Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
Li B; Department of Oncology, The Second Affiliated Hospital of Guilin Medical University, Guilin, People's Republic of China.
Zhang Z; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Discovery of Chinese Ministry of Education (MOE), Guangzhou City Key Laboratory of Precision Chemical Drug Development, School of Pharmacy, Jinan University, Guangzhou, People's Republic of China.
Li Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
Li Y; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Liu Z; Senior Department of Oncology, The 5th Medical Center of PLA General Hospital, Beijing, People's Republic of China.
Yang N; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
Wang H; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, People's Republic of China.
Huang W; Department of Pathology, the First Affiliated Hospital of Henan University of Science and Technology, Luoyang, People's Republic of China.
Hong Z; Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, People's Republic of China.
Wang G; Institute of Respiratory Diseases, Xinqiao Hospital, Third Military Medical University, Chongqing, People's Republic of China.
Wang J; Department of Pathology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Fang M; Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, People's Republic of China.
Fang Y; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, People's Republic of China.
Zhu X; Department of Radiation Oncology, Affiliated Jinling Hospital, Medical School of Nanjing, Nanjing, People's Republic of China.
Shen Y; Department of Thoracic Surgery, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Zhang Y; Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, People's Republic of China.
Ma S; Department of Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou Cancer Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Song Y; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Lu Y; Department of Clinical Pathology, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China.
Fang W; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Li Z; Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Wu L; The Second Department of Thoracic Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Central South University, Changsha, People's Republic of China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Nov; Vol. 14 (31), pp. 3166-3177. Date of Electronic Publication: 2023 Sep 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/diagnosis
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/diagnosis
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; In Situ Hybridization, Fluorescence ; Consensus ; Proto-Oncogene Proteins c-ret/genetics ; Gene Fusion
Czasopismo naukowe
Tytuł:
Ultra-sensitive molecular detection of gene fusions from RNA using ASPYRE.
Autorzy:
Gray ER; Biofidelity Ltd, 330 Cambridge Science Park, Milton road, CB4 0WN, Cambridge, England.
Mordaka JM; Biofidelity Ltd, 330 Cambridge Science Park, Milton road, CB4 0WN, Cambridge, England.
Christoforou ER; Biofidelity Ltd, 330 Cambridge Science Park, Milton road, CB4 0WN, Cambridge, England.
von Bargen K; Biofidelity Ltd, 330 Cambridge Science Park, Milton road, CB4 0WN, Cambridge, England.
Potts ND; Biofidelity Ltd, 330 Cambridge Science Park, Milton road, CB4 0WN, Cambridge, England.
Xyrafaki C; Biofidelity Ltd, 330 Cambridge Science Park, Milton road, CB4 0WN, Cambridge, England.
Silva AL; Biofidelity Ltd, 330 Cambridge Science Park, Milton road, CB4 0WN, Cambridge, England.
Stolarek-Januszkiewicz M; Biofidelity Ltd, 330 Cambridge Science Park, Milton road, CB4 0WN, Cambridge, England.
Anton K; Biofidelity Ltd, 330 Cambridge Science Park, Milton road, CB4 0WN, Cambridge, England.
Powalowska PK; Biofidelity Ltd, 330 Cambridge Science Park, Milton road, CB4 0WN, Cambridge, England.
Andreazza S; Biofidelity Ltd, 330 Cambridge Science Park, Milton road, CB4 0WN, Cambridge, England.
Tomassini A; Biofidelity Ltd, 330 Cambridge Science Park, Milton road, CB4 0WN, Cambridge, England.
Palmer RN; Biofidelity Ltd, 330 Cambridge Science Park, Milton road, CB4 0WN, Cambridge, England.
Cooke A; Biofidelity Ltd, 330 Cambridge Science Park, Milton road, CB4 0WN, Cambridge, England.
Osborne RJ; Biofidelity Ltd, 330 Cambridge Science Park, Milton road, CB4 0WN, Cambridge, England.
Balmforth BW; Biofidelity Ltd, 330 Cambridge Science Park, Milton road, CB4 0WN, Cambridge, England. .
Pokaż więcej
Źródło:
BMC medical genomics [BMC Med Genomics] 2022 Oct 12; Vol. 15 (1), pp. 215. Date of Electronic Publication: 2022 Oct 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Fusion*
RNA*/genetics
High-Throughput Nucleotide Sequencing/methods ; Mutation ; Sequence Analysis, RNA
Czasopismo naukowe
Tytuł:
Clinicopathologic features of an MXI1::NUTM1 fusion neoplasm; a new molecular variant of the family of NUTM1-rearranged neoplasm.
Autorzy:
Duan FL; Department of Pathology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Hou J; Department of Pathology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Guo P; Department of Pathology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Tan H; Department of Pathology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Dai J; Department of Pathology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Tang Z; Department of Pathology, Chengdu First People's Hospital, Chengdu, China.
Chen M; Department of Pathology, West China School of Medicine and West China Hospital, Sichuan University, Chengdu, China.
Liu Y; Department of Pathology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2022 Oct; Vol. 81 (4), pp. 536-539. Date of Electronic Publication: 2022 Aug 12.
Typ publikacji:
Letter
MeSH Terms:
Gene Fusion*
Neoplasms*
Basic Helix-Loop-Helix Transcription Factors/genetics ; Humans ; Oncogene Proteins, Fusion/genetics ; Transcription Factors/genetics ; Tumor Suppressor Proteins
Opinia redakcyjna
Tytuł:
A sustainable mouse karyotype created by programmed chromosome fusion.
Autorzy:
Wang LB; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China.; Bejing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China.
Li ZK; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China.; Bejing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China.
Wang LY; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China.; Bejing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China.
Xu K; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China.; Bejing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China.
Ji TT; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Mao YH; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China.; Bejing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China.
Ma SN; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.; College of Life Science, Northeast Agricultural University, Harbin 150030, China.
Liu T; Annoroad Gene Technology (Beijing) Co., Ltd., Beijing 100176, China.
Tu CF; Annoroad Gene Technology (Beijing) Co., Ltd., Beijing 100176, China.
Zhao Q; Annoroad Gene Technology (Beijing) Co., Ltd., Beijing 100176, China.
Fan XN; Annoroad Gene Technology (Beijing) Co., Ltd., Beijing 100176, China.
Liu C; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China.; Bejing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China.
Wang LY; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Shu YJ; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Yang N; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Zhou Q; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China.; Bejing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China.
Li W; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China.; Bejing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2022 Aug 26; Vol. 377 (6609), pp. 967-975. Date of Electronic Publication: 2022 Aug 25.
Typ publikacji:
Journal Article
MeSH Terms:
Artificial Gene Fusion*/methods
Gene Editing*/methods
Karyotype*
Translocation, Genetic*
Animals ; Chromatin/chemistry ; Embryonic Stem Cells ; Haploidy ; Mice ; Mitosis
Czasopismo naukowe
Tytuł:
Cost-Efficient Detection of NTRK1/2/3 Gene Fusions: Single-Center Analysis of 8075 Tumor Samples.
Autorzy:
Romanko, Aleksandr A. (AUTHOR)
Mulkidjan, Rimma S. (AUTHOR)
Tiurin, Vladislav I. (AUTHOR)
Saitova, Evgeniya S. (AUTHOR)
Preobrazhenskaya, Elena V. (AUTHOR)
Krivosheyeva, Elena A. (AUTHOR)
Mitiushkina, Natalia V. (AUTHOR)
Shestakova, Anna D. (AUTHOR)
Belogubova, Evgeniya V. (AUTHOR)
Ivantsov, Alexandr O. (AUTHOR)
Iyevleva, Aglaya G. (AUTHOR)
Imyanitov, Evgeny N. (AUTHOR)
Pokaż więcej
Źródło:
International Journal of Molecular Sciences. Sep2023, Vol. 24 Issue 18, p14203. 12p.
Czasopismo naukowe
Tytuł:
ALK , ROS1 , RET and NTRK1–3 Gene Fusions in Colorectal and Non-Colorectal Microsatellite-Unstable Cancers.
Autorzy:
Mulkidjan, Rimma S. (AUTHOR)
Saitova, Evgeniya S. (AUTHOR)
Preobrazhenskaya, Elena V. (AUTHOR)
Asadulaeva, Karimat A. (AUTHOR)
Bubnov, Mikhail G. (AUTHOR)
Otradnova, Ekaterina A. (AUTHOR)
Terina, Darya M. (AUTHOR)
Shulga, Sofia S. (AUTHOR)
Martynenko, Darya E. (AUTHOR)
Semina, Maria V. (AUTHOR)
Belogubova, Evgeniya V. (AUTHOR)
Tiurin, Vladislav I. (AUTHOR)
Amankwah, Priscilla S. (AUTHOR)
Martianov, Aleksandr S. (AUTHOR)
Imyanitov, Evgeny N. (AUTHOR)
Pokaż więcej
Źródło:
International Journal of Molecular Sciences. Sep2023, Vol. 24 Issue 17, p13610. 11p.
Czasopismo naukowe
Tytuł:
Rare FGFR fusion genes in cervical cancer and transcriptome‐based subgrouping of patients with a poor prognosis.
Autorzy:
Hiranuma, Kengo (AUTHOR)
Asami, Yuka (AUTHOR)
Kato, Mayumi Kobayashi (AUTHOR)
Murakami, Naoya (AUTHOR)
Shimada, Yoko (AUTHOR)
Matsuda, Maiko (AUTHOR)
Yazaki, Shu (AUTHOR)
Fujii, Erisa (AUTHOR)
Sudo, Kazuki (AUTHOR)
Kuno, Ikumi (AUTHOR)
Komatsu, Masaaki (AUTHOR)
Hamamoto, Ryuji (AUTHOR)
Makinoshima, Hideki (AUTHOR)
Matsumoto, Koji (AUTHOR)
Ishikawa, Mitsuya (AUTHOR)
Kohno, Takashi (AUTHOR)
Terao, Yasuhisa (AUTHOR)
Itakura, Atsuo (AUTHOR)
Yoshida, Hiroshi (AUTHOR)
Shiraishi, Kouya (AUTHOR)
Pokaż więcej
Źródło:
Cancer Medicine. Sep2023, Vol. 12 Issue 17, p17835-17848. 14p.
Czasopismo naukowe
Tytuł:
Eccrine Poroma: Pathogenesis, New Diagnostic Tools and Association with Porocarcinoma—A Review.
Autorzy:
Kyrmanidou, Eirini (AUTHOR)
Fotiadou, Christina (AUTHOR)
Kemanetzi, Christina (AUTHOR)
Trakatelli, Myrto-Georgia (AUTHOR)
Trigoni, Anastasia (AUTHOR)
Patsatsi, Aikaterini (AUTHOR)
Apalla, Zoe (AUTHOR)
Lazaridou, Elizabeth (AUTHOR)
Pokaż więcej
Źródło:
Diagnostics (2075-4418). Aug2023, Vol. 13 Issue 16, p2689. 10p.
Czasopismo naukowe
Tytuł:
Fusion Tag Design Influences Soluble Recombinant Protein Production in Escherichia coli .
Autorzy:
Köppl C; Austrian Centre of Industrial Biotechnology, Muthgasse 18, 1190 Vienna, Austria.; Department of Biotechnology, Institute of Bioprocess Science and Engineering, University of Natural Resources and Life Sciences, Muthgasse 18, 1190 Vienna, Austria.
Lingg N; Austrian Centre of Industrial Biotechnology, Muthgasse 18, 1190 Vienna, Austria.; Department of Biotechnology, Institute of Bioprocess Science and Engineering, University of Natural Resources and Life Sciences, Muthgasse 18, 1190 Vienna, Austria.
Fischer A; Austrian Centre of Industrial Biotechnology, Muthgasse 18, 1190 Vienna, Austria.
Kröß C; Austrian Centre of Industrial Biotechnology, Muthgasse 18, 1190 Vienna, Austria.; Center for Molecular Biosciences Innsbruck (CMBI), Institute of Biochemistry, University of Innsbruck, Innrain 52, 6020 Innsbruck, Austria.
Loibl J; Austrian Centre of Industrial Biotechnology, Muthgasse 18, 1190 Vienna, Austria.
Buchinger W; Biopharma Austria, Process Science, Boehringer Ingelheim Regional Center Vienna GmbH & Co KG, Doktor-Boehringer-Gasse 5-11, 1121 Vienna, Austria.
Schneider R; Austrian Centre of Industrial Biotechnology, Muthgasse 18, 1190 Vienna, Austria.; Center for Molecular Biosciences Innsbruck (CMBI), Institute of Biochemistry, University of Innsbruck, Innrain 52, 6020 Innsbruck, Austria.
Jungbauer A; Austrian Centre of Industrial Biotechnology, Muthgasse 18, 1190 Vienna, Austria.; Department of Biotechnology, Institute of Bioprocess Science and Engineering, University of Natural Resources and Life Sciences, Muthgasse 18, 1190 Vienna, Austria.
Striedner G; Austrian Centre of Industrial Biotechnology, Muthgasse 18, 1190 Vienna, Austria.; Department of Biotechnology, Institute of Bioprocess Science and Engineering, University of Natural Resources and Life Sciences, Muthgasse 18, 1190 Vienna, Austria.
Cserjan-Puschmann M; Austrian Centre of Industrial Biotechnology, Muthgasse 18, 1190 Vienna, Austria.; Department of Biotechnology, Institute of Bioprocess Science and Engineering, University of Natural Resources and Life Sciences, Muthgasse 18, 1190 Vienna, Austria.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Jul 12; Vol. 23 (14). Date of Electronic Publication: 2022 Jul 12.
Typ publikacji:
Journal Article
MeSH Terms:
Escherichia coli*/genetics
Escherichia coli*/metabolism
Gene Fusion*
Humans ; Recombinant Fusion Proteins/metabolism ; Recombinant Proteins/genetics ; Recombinant Proteins/metabolism ; Solubility
Czasopismo naukowe
Tytuł:
Letter to the Editor Regarding "Local ALK-Positive Histiocytosis with Unusual Morphology and Novel TRIM33::ALK Gene Fusion" by Tran et al.
Autorzy:
Soylemez Akkurt T; Pathology Department, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Dur Karasayar AH; Pathology Department, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Gurbuz BC; Pathology Department, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Altınay S; Pathology Department, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Yuzkan S; Radiology Department, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Baskan F; Neurosurgery Department, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2023 Oct; Vol. 31 (7), pp. 1426-1429. Date of Electronic Publication: 2022 Dec 05.
Typ publikacji:
Letter; Comment
MeSH Terms:
Histiocytosis*/diagnosis
Histiocytosis*/genetics
Lung Neoplasms*/genetics
Humans ; Receptor Protein-Tyrosine Kinases ; Gene Fusion ; Oncogene Proteins, Fusion/genetics ; Transcription Factors/genetics
Opinia redakcyjna
Tytuł:
SlWRKY16 and SlWRKY31 of tomato, negative regulators of plant defense, involved in susceptibility activation following root-knot nematode Meloidogyne javanica infection.
Autorzy:
Kumar A; Department of Entomology, Nematology and Chemistry Units, Agricultural Research Organization (ARO), Volcani Center, 50250, Bet Dagan, Israel.
Sichov N; Department of Entomology, Nematology and Chemistry Units, Agricultural Research Organization (ARO), Volcani Center, 50250, Bet Dagan, Israel.
Bucki P; Department of Entomology, Nematology and Chemistry Units, Agricultural Research Organization (ARO), Volcani Center, 50250, Bet Dagan, Israel.
Miyara SB; Department of Entomology, Nematology and Chemistry Units, Agricultural Research Organization (ARO), Volcani Center, 50250, Bet Dagan, Israel. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 05; Vol. 13 (1), pp. 14592. Date of Electronic Publication: 2023 Sep 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Solanum lycopersicum*
Tylenchoidea*
Nematode Infections*
Animals ; Gene Fusion ; Genes, Reporter
Czasopismo naukowe
Tytuł:
Remaining useful life prognosis of turbofan engines based on deep feature extraction and fusion.
Autorzy:
Peng C; Hunan University of Technology, Zhuzhou, 412007, China. .; Central South University, Changsha, 410083, China. .
Chen Y; Hunan University of Technology, Zhuzhou, 412007, China.
Gui W; Central South University, Changsha, 410083, China.
Tang Z; Central South University, Changsha, 410083, China.
Li C; Hunan University of Technology, Zhuzhou, 412007, China.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Apr 20; Vol. 12 (1), pp. 6491. Date of Electronic Publication: 2022 Apr 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Algorithms*
Gene Fusion*
Computer Simulation ; Prognosis
Czasopismo naukowe
Tytuł:
Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3-MAML2 fusions, and clinicopathological features.
Autorzy:
Nakano S; Department of Pathology and Molecular Diagnostics, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.
Okumura Y; Department of Pathology and Molecular Diagnostics, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.; Department of Maxillofacial Surgery, School of Dentistry, Aichi-Gakuin University, Nagoya, Japan.
Murase T; Department of Pathology and Molecular Diagnostics, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.
Nagao T; Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan.
Kusafuka K; Department of Pathology, Shizuoka General Hospital, Shizuoka, Japan.
Urano M; Department of Diagnostic Pathology, Fujita Health University, School of Medicine, Bantane Hospital, Nagoya, Japan.
Yamamoto H; Department of Anatomic Pathology, Graduate of School of Medical Science, Kyushu University, Fukuoka, Japan.
Kano S; Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Tsukahara K; Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan.
Okami K; Department of Otolaryngology-Head and Neck Surgery, Tokai University School of Medicine, Isehara, Japan.
Kawakita D; Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.
Nagao T; Department of Maxillofacial Surgery, School of Dentistry, Aichi-Gakuin University, Nagoya, Japan.
Hanai N; Department of Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.
Iwai H; Department of Otolaryngology, Head and Neck Surgery, Kansai Medical University, Hirakata, Japan.
Kawata R; Department of Otorhinolaryngology-Head and Neck Surgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Tada Y; Department of Head and Neck Oncology and Surgery, International University of Health and Welfare, Mita Hospital, Tokyo, Japan.
Nibu KI; Department of Otolaryngology-Head and Neck Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
Inagaki H; Department of Pathology and Molecular Diagnostics, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2022 Mar; Vol. 80 (4), pp. 729-735. Date of Electronic Publication: 2021 Dec 14.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Gene Fusion*
Carcinoma, Mucoepidermoid/*genetics
Carcinoma, Mucoepidermoid/*pathology
Salivary Gland Neoplasms/*genetics
Salivary Gland Neoplasms/*pathology
Trans-Activators/*genetics
Transcription Factors/*genetics
Female ; Humans ; Male ; Neoplasm Grading
Czasopismo naukowe
Tytuł:
Cutaneous nodular fasciitis with rare TPM4-USP6 fusion.
Autorzy:
Rodriguez Pena MDC; Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Morlote D; Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Prieto Granada CN; Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Pokaż więcej
Źródło:
Journal of cutaneous pathology [J Cutan Pathol] 2022 Feb; Vol. 49 (2), pp. 196-199. Date of Electronic Publication: 2021 Oct 29.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Gene Fusion*
Fasciitis/*pathology
Myofibroma/*pathology
Skin Neoplasms/*pathology
Tropomyosin/*genetics
Ubiquitin Thiolesterase/*genetics
Adult ; Cheek ; Fasciitis/genetics ; Humans ; Male ; Myofibroma/genetics ; Skin Neoplasms/genetics
Czasopismo naukowe
Tytuł:
Advances in the classification of round cell sarcomas.
Autorzy:
Le Loarer F; Université de Bordeaux, Talence, France.; Département de Biopathologie, Bordeaux, France.; INSERM U1218, ACTION, Bordeaux, France.
Baud J; Université de Bordeaux, Talence, France.; INSERM U1218, ACTION, Bordeaux, France.
Azmani R; Department of Bioinformatics, Bordeaux, France.
Michot A; Université de Bordeaux, Talence, France.; INSERM U1218, ACTION, Bordeaux, France.; Department of Surgery, Institut Bergonie, Bordeaux, France.
Karanian M; Département de Biopathologie, Centre Leon Berard, Lyon, France.; INSERM U1052, Cancer Research Centre of Lyon, Lyon, France.
Pissaloux D; Département de Biopathologie, Centre Leon Berard, Lyon, France.; INSERM U1052, Cancer Research Centre of Lyon, Lyon, France.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2022 Jan; Vol. 80 (1), pp. 33-53.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Gene Fusion*
Bone Neoplasms/*diagnosis
Liposarcoma, Myxoid/*diagnosis
Soft Tissue Neoplasms/*diagnosis
Biomarkers, Tumor/genetics ; Bone Neoplasms/genetics ; Bone Neoplasms/pathology ; Gene Rearrangement ; Humans ; Kruppel-Like Transcription Factors/genetics ; Liposarcoma, Myxoid/genetics ; Liposarcoma, Myxoid/pathology ; NFATC Transcription Factors/genetics ; Repressor Proteins/genetics ; Soft Tissue Neoplasms/genetics ; Soft Tissue Neoplasms/pathology ; Translocation, Genetic
Czasopismo naukowe
Tytuł:
Hierarchical shared transfer learning for biomedical named entity recognition.
Autorzy:
Chai Z; College of Information Science and Technology, Beijing University of Chemical Technology, Beijing, China.
Jin H; College of Information Science and Technology, Beijing University of Chemical Technology, Beijing, China.
Shi S; College of Information Science and Technology, Beijing University of Chemical Technology, Beijing, China. .
Zhan S; School of Public Health, Peking University, Beijing, China. .
Zhuo L; Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.
Yang Y; National Institute of Health Data Science, Peking University, Beijing, China.
Pokaż więcej
Źródło:
BMC bioinformatics [BMC Bioinformatics] 2022 Jan 04; Vol. 23 (1), pp. 8. Date of Electronic Publication: 2022 Jan 04.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Fusion*
Information Storage and Retrieval*
Machine Learning
Czasopismo naukowe
Tytuł:
Characterization and evaluation of gene fusions as a measure of genetic instability and disease prognosis in prostate cancer.
Autorzy:
Schimmelpfennig C; Department of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Rade M; Department of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Füssel S; Department of Urology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Löffler D; Department of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Blumert C; Department of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Bertram C; Department of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Borkowetz A; Department of Urology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Otto DJ; Department of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Puppel SH; Department of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Hönscheid P; Institute of Pathology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Sommer U; Institute of Pathology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Baretton GB; Institute of Pathology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Köhl U; Department of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.; Institute of Clinical Immunology, Medical Faculty, University Hospital, University of Leipzig, Leipzig, Germany.
Wirth M; Department of Urology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Thomas C; Department of Urology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Horn F; Department of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Kreuz M; Department of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Reiche K; Department of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany. .; Institute of Clinical Immunology, Medical Faculty, University Hospital, University of Leipzig, Leipzig, Germany. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Jun 22; Vol. 23 (1), pp. 575. Date of Electronic Publication: 2023 Jun 22.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/pathology
Male ; Humans ; Prognosis ; Neoplasm Grading ; Transcriptome ; Gene Fusion ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism
Czasopismo naukowe
Tytuł:
Transcript-targeted analysis reveals isoform alterations and double-hop fusions in breast cancer.
Autorzy:
Namba S; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.; Department of Statistical Genetics, Osaka University Graduate School of Medicine, Osaka, 565-0871, Japan.
Ueno T; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
Kojima S; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
Kobayashi K; Department of Head and Neck Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
Kawase K; Division of Cell Therapy, Chiba Cancer Center, Research Institute, Chiba, 260-8717, Japan.
Tanaka Y; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
Inoue S; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
Kishigami F; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
Kawashima S; Division of Cell Therapy, Chiba Cancer Center, Research Institute, Chiba, 260-8717, Japan.
Maeda N; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Yamaguchi, 755-8505, Japan.
Ogawa T; Department of Breast Surgery, Mie University Hospital, Mie, 514-8507, Japan.
Hazama S; Department of Translational Research and Developmental Therapeutics against Cancer, Yamaguchi University Graduate School of Medicine, Yamaguchi, 755-8505, Japan.
Togashi Y; Division of Cell Therapy, Chiba Cancer Center, Research Institute, Chiba, 260-8717, Japan.
Ando M; Department of Otolaryngology, Head and Neck Surgery, The University of Tokyo Hospital, Tokyo, 113-8654, Japan.
Shiraishi Y; Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
Mano H; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
Kawazu M; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, 104-0045, Japan. .; Division of Cell Therapy, Chiba Cancer Center, Research Institute, Chiba, 260-8717, Japan. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2021 Nov 22; Vol. 4 (1), pp. 1320. Date of Electronic Publication: 2021 Nov 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Fusion*
Transcriptome*
Breast Neoplasms/*genetics
Breast Neoplasms/metabolism ; Humans ; Protein Isoforms/metabolism ; RNA/analysis ; Tensins/genetics ; Tensins/metabolism
Czasopismo naukowe
Tytuł:
The Fusion of CLEC12A and MIR223HG Arises from a trans -Splicing Event in Normal and Transformed Human Cells.
Autorzy:
Dhungel BP; Gene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.; Faculty of Medicine & Health, The University of Sydney, Camperdown, NSW 2006, Australia.
Monteuuis G; Department of Biochemistry and Developmental Biology, University of Helsinki, 00014 Helsinki, Finland.
Giardina C; Gene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.
Tabar MS; Gene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.
Feng Y; Gene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.
Metierre C; Gene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.
Ho S; Gene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.
Nagarajah R; Gene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.
Fontaine ARM; Centenary Imaging and Sydney Cytometry Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.
Shah JS; Gene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.
Gokal D; Gene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.; Faculty of Medicine & Health, The University of Sydney, Camperdown, NSW 2006, Australia.
Bailey CG; Gene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.; Faculty of Medicine & Health, The University of Sydney, Camperdown, NSW 2006, Australia.; Cancer & Gene Regulation Laboratory Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.
Schmitz U; Department of Molecular & Cell Biology, College of Public Health, Medical & Vet Sciences, James Cook University, Townsville, QLD 4811, Australia.
Rasko JEJ; Gene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.; Faculty of Medicine & Health, The University of Sydney, Camperdown, NSW 2006, Australia.; Cell and Molecular Therapies, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Nov 10; Vol. 22 (22). Date of Electronic Publication: 2021 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Fusion*
Trans-Splicing*
Lectins, C-Type/*genetics
Leukemia, Myeloid/*genetics
MicroRNAs/*genetics
Mutant Chimeric Proteins/*genetics
Receptors, Mitogen/*genetics
Antineoplastic Agents/pharmacology ; Apoptosis/drug effects ; Cell Differentiation/genetics ; Cell Line ; Cytarabine/pharmacology ; Humans ; Lectins, C-Type/metabolism ; Leukemia, Myeloid/metabolism ; MicroRNAs/metabolism ; Mutant Chimeric Proteins/metabolism ; Receptors, Mitogen/metabolism ; Transcriptional Activation
Czasopismo naukowe
Tytuł:
Factors Impacting Clinically Relevant RNA Fusion Assays Using Next-Generation Sequencing.
Autorzy:
Ramani NS; From the Department of Pathology (Ramani, Broaddus, Chen, Rashid, Lazar, Roy-Chowdhuri), The University of Texas MD Anderson Cancer Center, Houston.
Patel KP; Department of Hematopathology (Patel, Routbort, Alvarez, San Lucas, Manekia, Dang, Barkoh, Medeiros, Luthra), The University of Texas MD Anderson Cancer Center, Houston.
Routbort MJ; Department of Hematopathology (Patel, Routbort, Alvarez, San Lucas, Manekia, Dang, Barkoh, Medeiros, Luthra), The University of Texas MD Anderson Cancer Center, Houston.
Alvarez H; Department of Hematopathology (Patel, Routbort, Alvarez, San Lucas, Manekia, Dang, Barkoh, Medeiros, Luthra), The University of Texas MD Anderson Cancer Center, Houston.
Broaddus R; From the Department of Pathology (Ramani, Broaddus, Chen, Rashid, Lazar, Roy-Chowdhuri), The University of Texas MD Anderson Cancer Center, Houston.
Chen H; From the Department of Pathology (Ramani, Broaddus, Chen, Rashid, Lazar, Roy-Chowdhuri), The University of Texas MD Anderson Cancer Center, Houston.
Rashid A; From the Department of Pathology (Ramani, Broaddus, Chen, Rashid, Lazar, Roy-Chowdhuri), The University of Texas MD Anderson Cancer Center, Houston.
Lazar A; From the Department of Pathology (Ramani, Broaddus, Chen, Rashid, Lazar, Roy-Chowdhuri), The University of Texas MD Anderson Cancer Center, Houston.
Lucas FAS; Department of Hematopathology (Patel, Routbort, Alvarez, San Lucas, Manekia, Dang, Barkoh, Medeiros, Luthra), The University of Texas MD Anderson Cancer Center, Houston.
Yao H; Department of Bioinformatics and Computational Biology (Yao), The University of Texas MD Anderson Cancer Center, Houston. Broaddus is currently with the Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill.
Manekia J; Department of Hematopathology (Patel, Routbort, Alvarez, San Lucas, Manekia, Dang, Barkoh, Medeiros, Luthra), The University of Texas MD Anderson Cancer Center, Houston.
Dang H; Department of Hematopathology (Patel, Routbort, Alvarez, San Lucas, Manekia, Dang, Barkoh, Medeiros, Luthra), The University of Texas MD Anderson Cancer Center, Houston.
Barkoh BA; Department of Hematopathology (Patel, Routbort, Alvarez, San Lucas, Manekia, Dang, Barkoh, Medeiros, Luthra), The University of Texas MD Anderson Cancer Center, Houston.
Medeiros LJ; Department of Hematopathology (Patel, Routbort, Alvarez, San Lucas, Manekia, Dang, Barkoh, Medeiros, Luthra), The University of Texas MD Anderson Cancer Center, Houston.
Luthra R; Department of Hematopathology (Patel, Routbort, Alvarez, San Lucas, Manekia, Dang, Barkoh, Medeiros, Luthra), The University of Texas MD Anderson Cancer Center, Houston.
Roy-Chowdhuri S; From the Department of Pathology (Ramani, Broaddus, Chen, Rashid, Lazar, Roy-Chowdhuri), The University of Texas MD Anderson Cancer Center, Houston.
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2021 Nov 01; Vol. 145 (11), pp. 1405-1412.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Profiling*
Gene Fusion*
High-Throughput Nucleotide Sequencing*
Sequence Analysis, RNA*
Transcriptome*
Biomarkers, Tumor/*genetics
Neoplasms/*genetics
RNA, Neoplasm/*genetics
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biopsy ; Child ; Databases, Factual ; Female ; Humans ; Male ; Middle Aged ; Neoplasms/pathology ; Predictive Value of Tests ; Reproducibility of Results ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł:
Novel EGFL7-FOSB fusion in pseudomyogenic haemangioendothelioma with widely metastatic disease.
Autorzy:
Hakar MH; Department of Pathology, Oregon Health & Science University, USA.
White K; Department of Radiology, Oregon Health & Science University, USA.
Hansford BG; Department of Dermatology, Oregon Health & Science University, Portland, OR, USA.
Swensen J; Caris Life Sciences, Phoenix, AZ, USA.
Davis JL; Department of Pathology, Oregon Health & Science University, USA.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2021 Nov; Vol. 79 (5), pp. 888-891. Date of Electronic Publication: 2021 Sep 03.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Gene Fusion*
Hemangioendothelioma*/diagnostic imaging
Hemangioendothelioma*/drug therapy
Hemangioendothelioma*/pathology
EGF Family of Proteins/*genetics
Everolimus/*therapeutic use
Calcium-Binding Proteins/genetics ; Child ; Humans ; Male ; Proto-Oncogene Proteins c-fos/genetics ; Transcription Factors
Raport
Tytuł:
Radiological evidence of rapid growth acceleration of a small part solid nodule found to be large-cell carcinoma of the lung.
Autorzy:
Lu, Yunwei (AUTHOR)
Sun, Zewen (AUTHOR)
Li, Hao (AUTHOR)
Chen, Xiaofeng (AUTHOR)
Li, Yun (AUTHOR)
Sun, Lina (AUTHOR)
Yang, Fan (AUTHOR)
Jiang, Guanchao (AUTHOR)
Zhou, Jian (AUTHOR)
Pokaż więcej
Źródło:
Journal of Cardiothoracic Surgery. 7/24/2023, Vol. 18 Issue 1, p1-5. 5p.
Czasopismo naukowe
Tytuł:
Systematic discovery of gene fusions in pediatric cancer by integrating RNA-seq and WGS.
Autorzy:
van Belzen, Ianthe A. E. M. (AUTHOR)
Cai, Casey (AUTHOR)
van Tuil, Marc (AUTHOR)
Badloe, Shashi (AUTHOR)
Strengman, Eric (AUTHOR)
Janse, Alex (AUTHOR)
Verwiel, Eugène T. P. (AUTHOR)
van der Leest, Douwe F. M. (AUTHOR)
Kester, Lennart (AUTHOR)
Molenaar, Jan J. (AUTHOR)
Meijerink, Jules (AUTHOR)
Drost, Jarno (AUTHOR)
Peng, Weng Chuan (AUTHOR)
Kerstens, Hindrik H. D. (AUTHOR)
Tops, Bastiaan B. J. (AUTHOR)
Holstege, Frank C. P. (AUTHOR)
Kemmeren, Patrick (AUTHOR)
Hehir-Kwa, Jayne Y. (AUTHOR)
Pokaż więcej
Źródło:
BMC Cancer. 7/4/2023, Vol. 23 Issue 1, p1-14. 14p.
Czasopismo naukowe
Tytuł:
Achieving High Expression of Cry in Green Tissues and Negligible Expression in Endosperm Simultaneously via rbcS Gene Fusion Strategy in Rice.
Autorzy:
Chen, Hao (AUTHOR)
Huang, Yuqing (AUTHOR)
Ye, Mengnan (AUTHOR)
Wang, Ya (AUTHOR)
He, Xiuying (AUTHOR)
Tu, Jumin (AUTHOR)
Pokaż więcej
Źródło:
International Journal of Molecular Sciences. May2023, Vol. 24 Issue 10, p9045. 13p.
Czasopismo naukowe
Tytuł:
MALAT1 functions as a transcriptional promoter of MALAT1::GLI1 fusion for truncated GLI1 protein expression in cancer.
Autorzy:
Hamada, Taiji (AUTHOR)
Higashi, Michiyo (AUTHOR)
Yokoyama, Seiya (AUTHOR)
Akahane, Toshiaki (AUTHOR)
Hisaoka, Masanori (AUTHOR)
Noguchi, Hirotsugu (AUTHOR)
Furukawa, Tatsuhiko (AUTHOR)
Tanimoto, Akihide (AUTHOR)
Pokaż więcej
Źródło:
BMC Cancer. 5/10/2023, Vol. 23 Issue 1, p1-12. 12p.
Czasopismo naukowe
Tytuł:
A Novel NFIX-STAT6 Gene Fusion in Solitary Fibrous Tumor: A Case Report.
Autorzy:
Moura DS; Institute of Biomedicine of Seville (IBiS, CSIC, HUVR, US), 41013 Seville, Spain.
Díaz-Martín J; Institute of Biomedicine of Seville (IBiS, CSIC, HUVR, US), 41013 Seville, Spain.; Pathology Department, Hospital Virgen del Rocío, 41013 Sevilla, Spain.; Centro de Investigación Biomédica en Red del Cáncer (CIBERONC), 28029 Madrid, Spain.
Bagué S; Pathology Department-CIBERONC, Sant Pau Hospital, 08041 Barcelona, Spain.
Orellana-Fernandez R; Pathology Department-CIBERONC, Sant Pau Hospital, 08041 Barcelona, Spain.
Sebio A; Medical Oncology Department, Sant Pau Hospital, 08041 Barcelona, Spain.
Mondaza-Hernandez JL; Fundacion Jimenez Diaz University Hospital Health Research Institute (IIS/FJD), 28015 Madrid, Spain.
Salguero-Aranda C; Institute of Biomedicine of Seville (IBiS, CSIC, HUVR, US), 41013 Seville, Spain.; Pathology Department, Hospital Virgen del Rocío, 41013 Sevilla, Spain.; Centro de Investigación Biomédica en Red del Cáncer (CIBERONC), 28029 Madrid, Spain.
Rojo F; Pathology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain.
Hindi N; Fundacion Jimenez Diaz University Hospital Health Research Institute (IIS/FJD), 28015 Madrid, Spain.; Medical Oncology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain.; General de Villalba University Hospital, 28400 Madrid, Spain.
Fletcher CDM; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02215, USA.; Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.
Martin-Broto J; Fundacion Jimenez Diaz University Hospital Health Research Institute (IIS/FJD), 28015 Madrid, Spain.; Medical Oncology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain.; General de Villalba University Hospital, 28400 Madrid, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Jul 13; Vol. 22 (14). Date of Electronic Publication: 2021 Jul 13.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Gene Fusion*
NFI Transcription Factors/*genetics
Oncogene Proteins, Fusion/*genetics
STAT6 Transcription Factor/*genetics
Solitary Fibrous Tumors/*genetics
Solitary Fibrous Tumors/*pathology
Aged ; Female ; Humans ; Prognosis
Czasopismo naukowe
Tytuł:
Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer.
Autorzy:
Cho SH; Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea.
Yoon S; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Lee DH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim SW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. .
Kim K; Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea. .; Department of Biology, Kyung Hee University, Seoul, Republic of Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Oct 01; Vol. 11 (1), pp. 19596. Date of Electronic Publication: 2021 Oct 01.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Fusion*
Mutation*
Carcinoma, Non-Small-Cell Lung/*genetics
Lung Neoplasms/*genetics
Carcinoma, Non-Small-Cell Lung/pathology ; Disease-Free Survival ; Humans ; Lung Neoplasms/pathology ; Neoplasm Recurrence, Local/genetics ; Prognosis ; Selection, Genetic ; Signal Transduction/genetics
Czasopismo naukowe
Tytuł:
Predictive 'biomarker piggybacking': an examination of reflexive pan-cancer screening with pan-TRK immunohistochemistry.
Autorzy:
Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Zheng M; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Nardi V; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Hornick JL; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2021 Aug; Vol. 79 (2), pp. 260-264. Date of Electronic Publication: 2021 Apr 07.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Fusion*
Biomarkers, Tumor/*analysis
Early Detection of Cancer/*methods
Immunohistochemistry/*methods
Neoplasms/*genetics
Neoplasms/*pathology
Receptor Protein-Tyrosine Kinases/*analysis
Aged ; Aged, 80 and over ; Female ; Genetic Testing ; Humans ; Male ; Middle Aged ; Receptor Protein-Tyrosine Kinases/genetics ; Sequence Analysis, RNA
Czasopismo naukowe
Tytuł:
Pan-TRK Immunohistochemistry: An Example-Based Practical Approach to Efficiently Identify Patients With NTRK Fusion Cancer.
Autorzy:
Conde E; From Pathology and Laboratory of Therapeutic Targets, Hospital Universitario HM Sanchinarro, HMHospitales, CIBERONC, Madrid, Spain (Conde, Lopez-Rios).
Hernandez S; Pathology and Laboratory of Therapeutic Targets, Hospital Universitario HM Sanchinarro, HMHospitales, Madrid, Spain (Hernandez, Sanchez, Alonso, Martinez).
Sanchez E; Pathology and Laboratory of Therapeutic Targets, Hospital Universitario HM Sanchinarro, HMHospitales, Madrid, Spain (Hernandez, Sanchez, Alonso, Martinez).
Regojo RM; Pathology, Hospital Universitario La Paz, Madrid, Spain (Regojo).
Camacho C; Pathology, Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, Spain (Camacho). Conde and Hernandez contributed equally as co-first authors.
Alonso M; Pathology and Laboratory of Therapeutic Targets, Hospital Universitario HM Sanchinarro, HMHospitales, Madrid, Spain (Hernandez, Sanchez, Alonso, Martinez).
Martinez R; Pathology and Laboratory of Therapeutic Targets, Hospital Universitario HM Sanchinarro, HMHospitales, Madrid, Spain (Hernandez, Sanchez, Alonso, Martinez).
Lopez-Rios F; From Pathology and Laboratory of Therapeutic Targets, Hospital Universitario HM Sanchinarro, HMHospitales, CIBERONC, Madrid, Spain (Conde, Lopez-Rios).
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2021 Aug 01; Vol. 145 (8), pp. 1031-1040.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Gene Fusion*
Immunohistochemistry*
Biomarkers, Tumor/*genetics
Membrane Glycoproteins/*genetics
Neoplasms/*genetics
Receptor, trkA/*genetics
Receptor, trkB/*genetics
Receptor, trkC/*genetics
Genetic Predisposition to Disease ; High-Throughput Nucleotide Sequencing ; Humans ; In Situ Hybridization, Fluorescence ; Neoplasms/pathology ; Phenotype ; Predictive Value of Tests ; Prognosis ; Reverse Transcriptase Polymerase Chain Reaction
Czasopismo naukowe
Tytuł:
A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations.
Autorzy:
Stružinská I; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. .; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, Prague 2, 12800, Czech Republic. .
Hájková N; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Hojný J; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Krkavcová E; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Michálková R; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Dvořák J; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Němejcová K; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Matěj R; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.; Department of Pathology, Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, Prague, 3rd, Czech Republic.; Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University, Thomayer University Hospital, Prague, Czech Republic.
Laco J; The Fingerland Department of Pathology, Faculty of Medicine in Hradec Kralove, Charles University, University Hospital Hradec Kralove, Prague, Czech Republic.
Drozenová J; Department of Pathology, Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, Prague, 3rd, Czech Republic.
Fabian P; Department of Oncological Pathology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Hausnerová J; Department of Pathology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic.
Méhes G; Department of Pathology, Faculty of Medicine, University of Debrecen, Debrecen, 4032, Hungary.
Škapa P; Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Švajdler M; Šikl's Department of Pathology, The Faculty of Medicine, Faculty Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
Cibula D; Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic.
Frühauf F; Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic.
Bártů MK; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Dundr P; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. .; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, Prague 2, 12800, Czech Republic. .
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2023 Jun 12; Vol. 18 (1), pp. 72. Date of Electronic Publication: 2023 Jun 12.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*
Adenocarcinoma, Clear Cell*/genetics
Humans ; Gene Expression Profiling ; Gene Fusion ; Genomics
Czasopismo naukowe
Tytuł:
MTAP-ANRIL gene fusion promotes melanoma epithelial-mesenchymal transition-like process by activating the JNK and p38 signaling pathways.
Autorzy:
Lin Z; Department of Gastroenterology, Shangrao People's Hospital, Shangrao, 334000, Jiangxi Province, China.
Lei Y; Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei Province, China.; Institute of Liver and Gastrointestinal Diseases, Huazhong University of Science and Technology, Tongji Hospital of Tongji Medical CollegeWuhan, 430030, Hubei Province, China.
Wen M; Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei Province, China.
He Q; Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei Province, China.; Institute of Liver and Gastrointestinal Diseases, Huazhong University of Science and Technology, Tongji Hospital of Tongji Medical CollegeWuhan, 430030, Hubei Province, China.
Tian D; Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei Province, China.; Institute of Liver and Gastrointestinal Diseases, Huazhong University of Science and Technology, Tongji Hospital of Tongji Medical CollegeWuhan, 430030, Hubei Province, China.
Xie H; Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei Province, China. .; Institute of Liver and Gastrointestinal Diseases, Huazhong University of Science and Technology, Tongji Hospital of Tongji Medical CollegeWuhan, 430030, Hubei Province, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jun 05; Vol. 13 (1), pp. 9073. Date of Electronic Publication: 2023 Jun 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Epithelial-Mesenchymal Transition*/genetics
Melanoma*/genetics
Melanoma*/pathology
Humans ; Signal Transduction ; Exons ; Gene Fusion
Czasopismo naukowe
Tytuł:
A Rare Case of a Solitary Fibrous Tumor in a Child, Presenting as a Congenital Mass, Displaying NAB2ex4::STAT6ex2 Gene Fusion with an Incidental Ganglioneuroblastoma.
Autorzy:
Rao V; Department of Surgical Pathology, Tata Memorial Hospital (TMH), Narayana Health, Bengaluru, India.
Rekhi B; Department of Surgical Pathology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI) University, Parel, Mumbai, Maharashtra, India.; Division of Molecular Pathology and Translational Medicine, Tata Memorial Hospital (TMH), Homi Bhabha National Institute (HBNI) University, Parel, Mumbai, Maharashtra, India.
Abraham LK; Department of Pathology, Rajagiri Hospital, Aluva, Kerala, India.
Bapat P; Division of Molecular Pathology and Translational Medicine, Tata Memorial Hospital (TMH), Homi Bhabha National Institute (HBNI) University, Parel, Mumbai, Maharashtra, India.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2023 May; Vol. 31 (3), pp. 321-331. Date of Electronic Publication: 2022 Jun 16.
Typ publikacji:
Case Reports; Review; Journal Article
MeSH Terms:
Ganglioneuroblastoma*/genetics
Solitary Fibrous Tumors*/pathology
Humans ; Male ; Child ; Infant ; Gene Fusion ; Exons
Czasopismo naukowe
Tytuł:
Possible role of the collagen type I alpha 1–platelet‐derived growth factor beta chain fusion gene in the development of dermatofibrosarcoma protuberans with fibrosarcomatous transformation.
Autorzy:
Katsumata, Fuminori
Kamiya, Koji
Miyauchi, Hitomi
Okada, Hirofumi
Sato, Atsuko
Maekawa, Takeo
Komine, Mayumi
Ohtsuki, Mamitaro
Pokaż więcej
Źródło:
Journal of Cutaneous Immunology & Allergy. Aug2023, Vol. 6 Issue 4, p129-131. 3p.
Czasopismo naukowe
Tytuł:
Distant metastatic potential in primary renal sarcoma with MEIS1-NCOA2 gene fusion.
Autorzy:
Quiroga-Garza GM; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Lajara S; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Burgess MA; Division of Hematology/Medical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
John I; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2021 Jul; Vol. 79 (1), pp. 117-118. Date of Electronic Publication: 2021 May 06.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Gene Fusion*
Neoplasm Metastasis*/genetics
Kidney Neoplasms/*genetics
Kidney Neoplasms/*pathology
Myeloid Ecotropic Viral Integration Site 1 Protein/*genetics
Nuclear Receptor Coactivator 2/*genetics
Sarcoma/*genetics
Sarcoma/*pathology
Female ; Humans ; Kidney Neoplasms/diagnostic imaging ; Kidney Neoplasms/therapy ; Middle Aged ; Sarcoma/diagnostic imaging ; Sarcoma/therapy
Raport
Tytuł:
Diagnostic Utility of a Custom 34-Gene Anchored Multiplex PCR-Based Next-Generation Sequencing Fusion Panel for the Diagnosis of Bone and Soft Tissue Neoplasms With Identification of Novel USP6 Fusion Partners in Aneurysmal Bone Cysts.
Autorzy:
Dermawan JK; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato).
Cheng YW; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato).
Tu ZJ; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato).
Meyer A; The Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City (Meyer).
Habeeb O; The Department of Anatomic Pathology, Middlemore Hospital, Counties Manukau District Health Board, Auckland, New Zealand (Habeeb).
Zou Y; The Department of Pathology, Kaiser Permanente Oakland Medical Center, Oakland, California (Zou).
Goldblum JR; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato).
Billings SD; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato).
Kilpatrick SE; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato).
Reith JD; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato).
Shurtleff SA; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato).
Farkas DH; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato).
Rubin BP; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato).
Azzato EM; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato).
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2021 Jul 01; Vol. 145 (7), pp. 851-863.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Profiling*
Gene Fusion*
Multiplex Polymerase Chain Reaction*
Transcriptome*
Biomarkers, Tumor/*genetics
Bone Cysts, Aneurysmal/*genetics
Bone Neoplasms/*genetics
Soft Tissue Neoplasms/*genetics
Ubiquitin Thiolesterase/*genetics
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Bone Cysts, Aneurysmal/pathology ; Bone Neoplasms/pathology ; Child ; Child, Preschool ; Diagnosis, Differential ; Female ; Genetic Predisposition to Disease ; High-Throughput Nucleotide Sequencing ; Humans ; Infant ; Male ; Middle Aged ; Predictive Value of Tests ; Reproducibility of Results ; Soft Tissue Neoplasms/pathology ; Young Adult
Czasopismo naukowe
Tytuł:
Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion-positive prostate cancer.
Autorzy:
Yun JW; Veterans Health Service Medical Center, Veterans Medical Research Institute, Seoul, Korea.
Lee S; Precision Medicine Center, Seoul National University Bundang Hospital, Seongnam, South Korea.; Department of Pathology and Translational Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
Chun S; Department of Laboratory Medicine, Chonnam National University Medical School and Hospital, Gwangju, Korea.
Lee KW; School of Medicine, University of Queensland, Brisbane, Australia.
Kim J; Department of Biological Sciences, Sungkyunkwan University, Suwon, Korea.
Kim HS; Department of Biological Sciences, Sungkyunkwan University, Suwon, Korea.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2021 May; Vol. 11 (5), pp. e420.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Repositioning*
Gene Expression Profiling*
Gene Fusion*
Antineoplastic Agents/*therapeutic use
Prostatic Neoplasms/*drug therapy
Prostatic Neoplasms/*genetics
Serine Endopeptidases/*genetics
Humans ; Male ; Transcriptional Regulator ERG/genetics
Raport
Tytuł:
Identification of EWSR1-NFATC2 fusion in simple bone cysts.
Autorzy:
Hung YP; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Fisch AS; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Diaz-Perez JA; Department of Pathology and Laboratory Medicine, University of Miami, Miller School of Medicine, Miami, FL, USA.
Iafrate AJ; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Lennerz JK; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Nardi V; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Bredella MA; Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Raskin KA; Department of Orthopedics, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Lozano-Calderon SA; Department of Orthopedics, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Rosenberg AE; Department of Pathology and Laboratory Medicine, University of Miami, Miller School of Medicine, Miami, FL, USA.
Nielsen GP; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2021 May; Vol. 78 (6), pp. 849-856. Date of Electronic Publication: 2021 Mar 16.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Fusion*
Bone Cysts/*genetics
Femur/*pathology
Fibula/*pathology
Humerus/*pathology
NFATC Transcription Factors/*genetics
RNA-Binding Protein EWS/*genetics
Adolescent ; Bone Cysts/pathology ; Child, Preschool ; Female ; High-Throughput Nucleotide Sequencing ; Homeobox Protein Nkx-2.2 ; Homeodomain Proteins ; Humans ; Male ; Nuclear Proteins ; Transcription Factors ; Young Adult
Czasopismo naukowe
Tytuł:
Gene Fusion Detection in NSCLC Routine Clinical Practice: Targeted-NGS or FISH?
Autorzy:
Pecciarini, Lorenza (AUTHOR)
Brunetto, Emanuela (AUTHOR)
Grassini, Greta (AUTHOR)
De Pascali, Valeria (AUTHOR)
Ogliari, Francesca Rita (AUTHOR)
Talarico, Anna (AUTHOR)
Marra, Giovanna (AUTHOR)
Magliacane, Gilda (AUTHOR)
Redegalli, Miriam (AUTHOR)
Arrigoni, Gianluigi (AUTHOR)
Lazzari, Chiara (AUTHOR)
Gregorc, Vanesa (AUTHOR)
Bulotta, Alessandra (AUTHOR)
Doglioni, Claudio (AUTHOR)
Cangi, Maria Giulia (AUTHOR)
Pokaż więcej
Źródło:
Cells (2073-4409). Apr2023, Vol. 12 Issue 8, p1135. 12p.
Czasopismo naukowe
Tytuł:
Establishing an RNA fusions panel in soft tissue sarcoma with clinical validation.
Autorzy:
Huang, Xiaoqiang (AUTHOR)
Li, Guibin (AUTHOR)
Li, Linghua (AUTHOR)
Wang, Jian (AUTHOR)
Shen, Jianru (AUTHOR)
Chen, Yao (AUTHOR)
Yu, Wuzhong (AUTHOR)
Chen, Ailin (AUTHOR)
Wu, Tao (AUTHOR)
Ma, Ji (AUTHOR)
Ling, Bao (AUTHOR)
He, Liang (AUTHOR)
Chen, Xudan (AUTHOR)
Pokaż więcej
Źródło:
Scientific Reports. 3/16/2023, Vol. 13 Issue 1, p1-7. 7p.
Czasopismo naukowe
Tytuł:
Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours.
Autorzy:
O'Haire, Sophie (AUTHOR)
Franchini, Fanny (AUTHOR)
Kang, Yoon-Jung (AUTHOR)
Steinberg, Julia (AUTHOR)
Canfell, Karen (AUTHOR)
Desai, Jayesh (AUTHOR)
Fox, Stephen (AUTHOR)
IJzerman, Maarten (AUTHOR)
Pokaż więcej
Źródło:
Scientific Reports. 3/13/2023, Vol. 13 Issue 1, p1-10. 10p.
Czasopismo naukowe
Tytuł:
High accuracy of single‐molecule real‐time sequencing in detecting a rare α‐globin fusion gene in carrier screening population.
Autorzy:
Zhou, Qiao‐Miao (AUTHOR)
Jiang, Fan (AUTHOR)
Xu, Jing (AUTHOR)
Lin, Dan (AUTHOR)
Huang, Ren‐Liang (AUTHOR)
Zhou, Jian‐Ying (AUTHOR)
Qu, Yan‐Xia (AUTHOR)
Li, Dong‐Zhi (AUTHOR)
Pokaż więcej
Źródło:
Annals of Human Genetics. Mar2023, Vol. 87 Issue 1/2, p9-17. 9p.
Czasopismo naukowe
Tytuł:
NTRK‐rearranged spindle cell neoplasms are ubiquitous tumours of myofibroblastic lineage with a distinct methylation class.
Autorzy:
Tauziède‐Espariat, Arnault (AUTHOR)
Duchesne, Mathilde (AUTHOR)
Baud, Jessica (AUTHOR)
Le Quang, Mégane (AUTHOR)
Bochaton, Dorian (AUTHOR)
Azmani, Rihab (AUTHOR)
Croce, Sabrina (AUTHOR)
Hostein, Isabelle (AUTHOR)
Kesrouani, Carole (AUTHOR)
Guillemot, Delphine (AUTHOR)
Pierron, Gaëlle (AUTHOR)
Bourdeaut, Franck (AUTHOR)
Cardoen, Liesbeth (AUTHOR)
Hasty, Lauren (AUTHOR)
Lechapt, Emmanuèle (AUTHOR)
Métais, Alice (AUTHOR)
Chrétien, Fabrice (AUTHOR)
Puget, Stéphanie (AUTHOR)
Varlet, Pascale (AUTHOR)
Le Loarer, François (AUTHOR)
Pokaż więcej
Źródło:
Histopathology. Mar2023, Vol. 82 Issue 4, p596-607. 12p.
Czasopismo naukowe
Tytuł:
Single-cell heterogeneity and dynamic evolution of Ph-like acute lymphoblastic leukemia patient with novel TPR-PDGFRB fusion gene.
Autorzy:
Zhang, Xuehong (AUTHOR)
Hou, Zhijie (AUTHOR)
Huang, Dan (AUTHOR)
Wang, Furong (AUTHOR)
Gao, Beibei (AUTHOR)
Zhang, Chengtao (AUTHOR)
Zhou, Dong (AUTHOR)
Lou, Jiacheng (AUTHOR)
Wang, Haina (AUTHOR)
Gao, Yuan (AUTHOR)
Kang, Zhijie (AUTHOR)
Lu, Ying (AUTHOR)
Liu, Quentin (AUTHOR)
Yan, Jinsong (AUTHOR)
Pokaż więcej
Źródło:
Experimental Hematology & Oncology. 2/17/2023, Vol. 12 Issue 1, p1-6. 6p.
Czasopismo naukowe
Tytuł:
Gastroblastoma mimics the embryonic mesenchyme of the foregut: a case report.
Autorzy:
Sugimoto, Ryo (AUTHOR)
Uesugi, Noriyuki (AUTHOR)
Yamada, Noriyuki (AUTHOR)
Osakabe, Mitsumasa (AUTHOR)
Baba, Shigeaki (AUTHOR)
Yanagawa, Naoki (AUTHOR)
Akiyama, Yuji (AUTHOR)
Habano, Wataru (AUTHOR)
Sasaki, Akira (AUTHOR)
Oda, Yoshinao (AUTHOR)
Sugai, Tamotsu (AUTHOR)
Pokaż więcej
Źródło:
Diagnostic Pathology. 2/17/2023, Vol. 18 Issue 1, p1-10. 10p.
Czasopismo naukowe
Tytuł:
Multigene PCR using both cfDNA and cfRNA in the supernatant of pleural effusion achieves accurate and rapid detection of mutations and fusions of driver genes in patients with advanced NSCLC.
Autorzy:
Chen X; Department of Pathology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis And Thoracic Tumor Research Institute, Beijing, China.
Li K; Department of Pathology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis And Thoracic Tumor Research Institute, Beijing, China.
Liu Z; Department of Pathology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis And Thoracic Tumor Research Institute, Beijing, China.
Gai F; Medical Department, Amoy Diagnostics Co., Ltd., Xiamen, China.
Zhu G; Medical Department, Amoy Diagnostics Co., Ltd., Xiamen, China.
Lu S; Department of Oncology, Shanghai Chest Hospital Shanghai Jiaotong University, Shanghai, China.
Che N; Department of Pathology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis And Thoracic Tumor Research Institute, Beijing, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2021 Apr; Vol. 10 (7), pp. 2286-2292. Date of Electronic Publication: 2021 Mar 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Fusion*
Mutation*
Carcinoma, Non-Small-Cell Lung/*genetics
Cell-Free Nucleic Acids/*genetics
Lung Neoplasms/*genetics
Pleural Effusion, Malignant/*genetics
Anaplastic Lymphoma Kinase/genetics ; Carcinoma, Non-Small-Cell Lung/pathology ; DNA, Neoplasm ; Female ; Genes, erbB-1 ; Genes, erbB-2 ; Genes, ras ; Humans ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Pleural Effusion, Malignant/pathology ; Polymerase Chain Reaction/methods ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature.
Autorzy:
Bradová, Martina (AUTHOR)
Mosaieby, Elaheh (AUTHOR)
Michal, Michael (AUTHOR)
Vaněček, Tomáš (AUTHOR)
Ing, Stanislav Kormunda (AUTHOR)
Grossmann, Petr (AUTHOR)
Koshyk, Olena (AUTHOR)
Kinkor, Zdeněk (AUTHOR)
Laciok, Šimon (AUTHOR)
Nemcová, Antónia (AUTHOR)
Straka, Ľubomír (AUTHOR)
Farkas, Mihaela (AUTHOR)
Michal, Michal (AUTHOR)
Švajdler, Marián (AUTHOR)
Pokaż więcej
Źródło:
Histopathology. Apr2024, Vol. 84 Issue 5, p776-793. 18p.
Czasopismo naukowe
Tytuł:
Insights into the mechanisms and structure of breakage-fusion-bridge cycles in cervical cancer using long-read sequencing.
Autorzy:
Rodriguez, Isabel (AUTHOR)
Rossi, Nicole M. (AUTHOR)
Keskus, Ayse G. (AUTHOR)
Xie, Yi (AUTHOR)
Ahmad, Tanveer (AUTHOR)
Bryant, Asher (AUTHOR)
Lou, Hong (AUTHOR)
Paredes, Jesica Godinez (AUTHOR)
Milano, Rose (AUTHOR)
Rao, Nina (AUTHOR)
Tulsyan, Sonam (AUTHOR)
Boland, Joseph F. (AUTHOR)
Luo, Wen (AUTHOR)
Liu, Jia (AUTHOR)
O'Hanlon, Tim (AUTHOR)
Bess, Jazmyn (AUTHOR)
Mukhina, Vera (AUTHOR)
Gaykalova, Daria (AUTHOR)
Yuki, Yuko (AUTHOR)
Malik, Laksh (AUTHOR)
Pokaż więcej
Źródło:
American Journal of Human Genetics. Mar2024, Vol. 111 Issue 3, p544-561. 18p.
Czasopismo naukowe
Tytuł:
Evaluation of New Generation Sequencing (NGS)-Based Somatic Gene Variations and Real-Time Polymerase Chain Reaction (PCR)-Based Gene Fusions in Elderly and Young Acute Leukemia Patients: A Retrospective View.
Autorzy:
Erdoğdu, İbrahim Halil (AUTHOR)
Örenay-Boyacıoğlu, Seda (AUTHOR)
Boyacıoğlu, Olcay (AUTHOR)
Kahraman-Çetin, Nesibe (AUTHOR)
Kacar-Döger, Füruzan (AUTHOR)
Yavaşoğlu, İrfan (AUTHOR)
Bolaman, Ali Zahit (AUTHOR)
Pokaż więcej
Źródło:
Journal of Personalized Medicine. Feb2024, Vol. 14 Issue 2, p140. 10p.
Czasopismo naukowe
Tytuł:
Consensus Recommendations to Optimize the Detection and Reporting of NTRK Gene Fusions by RNA-Based Next-Generation Sequencing.
Autorzy:
Stockley TL; Laboratory Medicine Program, University Health Network, Toronto, ON M5G 2C4, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5R 0A3, Canada.; Advanced Molecular Diagnostics Laboratory, Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada.
Lo B; Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
Box A; Alberta Precision Laboratories, Calgary, AB T2N 7A4, Canada.
Gomez Corredor A; McGill University Health Center, Montreal, QC H4A 3J1, Canada.
DeCoteau J; Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5A9, Canada.
Desmeules P; IUCPQ-UL, Quebec Heart and Lung Institute, Quebec City, QC G1V 4G5, Canada.
Feilotter H; Kingston Health Sciences Centre, Kingston, ON K7L 2V7, Canada.; Department of Pathology and Molecular Medicine, Queens University, Kingston, ON K7L 3N6, Canada.
Grafodatskaya D; Hamilton Health Sciences Centre, Hamilton, ON L9C 1C4, Canada.; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON L8S 4K1, Canada.
Hawkins C; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5R 0A3, Canada.; Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
Huang WY; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5R 0A3, Canada.; Nova Scotia Health Authority, Halifax, NS B3H 2E2, Canada.; Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.
Izevbaye I; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 2R7, Canada.
Lepine G; Hopital Maisonneuve-Rosemont, Montreal, QC H1T 2M4, Canada.
Papadakis AI; Lady Davis Institute, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
Park PC; Shared Health Manitoba, Winnipeg, MB R3A 1R9, Canada.
Sheffield BS; William Osler Health System, Brampton, ON L6R 3J7, Canada.
Tran-Thanh D; CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal, QC H3T 1J4, Canada.
Yip S; BC Cancer, Vancouver, BC V5Z 4S6, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.
Sound Tsao M; Laboratory Medicine Program, University Health Network, Toronto, ON M5G 2C4, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5R 0A3, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Mar 31; Vol. 30 (4), pp. 3989-3997. Date of Electronic Publication: 2023 Mar 31.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Receptor, trkA*/genetics
Receptor, trkA*/therapeutic use
Neoplasms*/drug therapy
Humans ; RNA/therapeutic use ; Consensus ; Oncogene Proteins, Fusion/genetics ; Canada ; High-Throughput Nucleotide Sequencing ; Gene Fusion
Czasopismo naukowe
Tytuł:
Recurrent RET fusions in fibrosarcoma-like neoplasms in adult viscera: expanding the clinicopathological and genetic spectrum.
Autorzy:
Zhao M; Cancer Center, Department of Pathology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Yin X; Department of Pathology, Hangzhou Women's Hospital, Hangzhou, China.
He H; Department of Pathology, School of Basic Medical Sciences, Third Hospital, Peking University Health Science Center, Beijing, China.
Xia Q; Department of Pathology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Ru G; Cancer Center, Department of Pathology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2023 Mar; Vol. 82 (4), pp. 633-645. Date of Electronic Publication: 2022 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
Fibrosarcoma*
Soft Tissue Neoplasms*/genetics
Female ; Humans ; Male ; Adult ; Child ; Viscera/pathology ; Neoplasm Recurrence, Local ; Gene Fusion ; Transcription Factors/genetics ; Proto-Oncogene Proteins c-ret/genetics
Czasopismo naukowe
Tytuł:
Successful Haploidentical Hematopoietic Stem Cell Transplantation with Azacitidine and Venetoclax Maintenance Therapy for Acute Myeloid Leukemia with NUP98-RARG Gene Fusion
Autorzy:
Yuan J; The Affiliated People’s Hospital of Ningbo University, Department of Hematology, Ningbo, Zhejiang, China
Pei R; The Affiliated People’s Hospital of Ningbo University, Department of Hematology, Ningbo, Zhejiang, China
Lu Y; The Affiliated People’s Hospital of Ningbo University, Department of Hematology, Ningbo, Zhejiang, China
Pokaż więcej
Źródło:
Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2023 Feb 28; Vol. 40 (1), pp. 75-76. Date of Electronic Publication: 2022 Dec 02.
Typ publikacji:
Journal Article
MeSH Terms:
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/therapy
Hematopoietic Stem Cell Transplantation*
Humans ; Azacitidine/therapeutic use ; Gene Fusion ; Nuclear Pore Complex Proteins/genetics
Czasopismo naukowe
Tytuł:
Reconsideration of the pathogenic significance of kinase gene fusion in melanocytic tumors based on a case of melanoma with non-in-frame BICD1::BRAF fusion.
Autorzy:
Takai T; Department of Dermatology, Hyogo Cancer Center, Akashi, Japan.
Sudo T; Section of Translational Research, Hyogo Cancer Center, Akashi, Japan.; Department of Gynecologic Oncology, Hyogo Cancer Center, Akashi, Japan.
Kajimoto K; Department of Diagnostic Pathology, Hyogo Cancer Center, Akashi, Japan.
Goto K; Department of Dermatology, Hyogo Cancer Center, Akashi, Japan.; Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan.; Department of Pathology, Itabashi Central Clinical Laboratory, Tokyo, Japan.; Department of Diagnostic Pathology, Tokyo Medical University Hospital, Tokyo, Japan.; Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Sunto, Japan.; Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.; Department of Diagnostic Pathology, Osaka National Hospital, Osaka, Japan.; Department of Dermato-Oncology/Dermatology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan.
Pokaż więcej
Źródło:
Journal of cutaneous pathology [J Cutan Pathol] 2023 Feb; Vol. 50 (2), pp. 185-187. Date of Electronic Publication: 2022 Nov 23.
Typ publikacji:
Case Reports; Journal Article; Comment
MeSH Terms:
Melanoma*/genetics
Melanoma*/pathology
Skin Neoplasms*/genetics
Skin Neoplasms*/pathology
Nevus, Epithelioid and Spindle Cell*
Humans ; Proto-Oncogene Proteins B-raf/genetics ; Gene Fusion ; Cytoskeletal Proteins/genetics ; Adaptor Proteins, Signal Transducing/genetics
Czasopismo naukowe
Tytuł:
Primary Pulmonary Myxoid Sarcoma with EWSR1::ATF1 Fusion: A Case Report.
Autorzy:
Nishimura T; Division of Thoracic Surgery, 89662Ayabe City Hospital, Kyoto, Japan.
Ii T; Division of Thoracic Surgery, 89662Ayabe City Hospital, Kyoto, Japan.
Inamori O; Division of Diagnostic Pathology, 89662Ayabe City Hospital, Kyoto, Japan.
Konishi E; Department of Surgical Pathology, Graduate School of Medical Science, 12898Kyoto Prefectural University of Medicine, Kyoto, Japan.
Yoshida A; Department of Diagnostic Pathology, 13874National Cancer Center, Tokyo, Japan.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2023 Feb; Vol. 31 (1), pp. 88-91. Date of Electronic Publication: 2022 Apr 24.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Sarcoma*/diagnosis
Sarcoma*/genetics
Sarcoma*/surgery
Male ; Humans ; Aged ; In Situ Hybridization, Fluorescence ; RNA-Binding Protein EWS/genetics ; Gene Fusion ; Oncogene Proteins, Fusion/genetics
Czasopismo naukowe
Tytuł:
Imaging findings, clinical and pathological characters of 28 patients with Xp11.2/TFE3 translocation renal cell carcinoma.
Autorzy:
Dong H; Department of Radiology, Fujian Maternity and Child Health Hospital, Fuzhou, Fujian, China.
Ni Y; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China.
Liu Z; Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China.
Wang Z; Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China.
Hu B; Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China.
Xu H; Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China.
Cai S; Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Feb; Vol. 19 (1), pp. 132-140.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Renal Cell*/diagnostic imaging
Carcinoma, Renal Cell*/genetics
Carcinoma, Renal Cell*/pathology
Kidney Neoplasms*/diagnostic imaging
Kidney Neoplasms*/genetics
Kidney Neoplasms*/pathology
Adult ; Adolescent ; Child ; Humans ; Middle Aged ; Child, Preschool ; Young Adult ; Aged ; Aged, 80 and over ; Translocation, Genetic ; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/genetics ; Gene Fusion ; Retrospective Studies
Czasopismo naukowe
Tytuł:
A rare case of a solitary fibrous tumor of vulva, displaying NAB2ex6-STAT6ex17 fusion.
Autorzy:
Rekhi B; Department of Surgical Pathology, Tata Memorial Centre, HBNI; Division of Molecular Biology and Translational Medicine, Tata Memorial Centre, HBNI University, Parel, Mumbai, Maharashtra, India.
Bapat P; Division of Molecular Biology and Translational Medicine, Tata Memorial Centre, HBNI University, Parel, Mumbai, Maharashtra, India.
Jindal A; Department of Pathology, SMS Medical College, Jaipur, Rajasthan, India.
Pokaż więcej
Źródło:
Indian journal of pathology & microbiology [Indian J Pathol Microbiol] 2021 Jan-Mar; Vol. 64 (1), pp. 177-179.
Typ publikacji:
Case Reports
MeSH Terms:
Gene Fusion*
Repressor Proteins/*genetics
STAT6 Transcription Factor/*genetics
Solitary Fibrous Tumors/*diagnostic imaging
Solitary Fibrous Tumors/*genetics
Vulva/*pathology
Biomarkers, Tumor/analysis ; Female ; Hemangiopericytoma ; Humans ; Immunohistochemistry ; Magnetic Resonance Imaging ; Paraffin Embedding ; Solitary Fibrous Tumors/pathology ; Young Adult
Raport
Tytuł:
annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions.
Autorzy:
Gaonkar KS; Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Bioinformatics and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Division of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Marini F; Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.; Center for Thrombosis and Hemostasis, Mainz, Germany.
Rathi KS; Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Bioinformatics and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Division of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Jain P; Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Division of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Zhu Y; Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Division of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Chimicles NA; Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Bioinformatics and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Brown MA; Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Division of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Naqvi AS; Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Bioinformatics and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Division of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Zhang B; Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Division of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Storm PB; Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Division of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Maris JM; Division of Oncology, Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Raman P; Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Bioinformatics and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Division of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Resnick AC; Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Bioinformatics and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Division of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Strauch K; Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Taroni JN; Alex's Lemonade Stand Foundation Childhood Cancer Data Lab, Philadelphia, PA, USA.
Rokita JL; Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA. .; Department of Bioinformatics and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA. .; Division of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, PA, USA. .
Pokaż więcej
Źródło:
BMC bioinformatics [BMC Bioinformatics] 2020 Dec 14; Vol. 21 (1), pp. 577. Date of Electronic Publication: 2020 Dec 14.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Fusion*
Software*
Neoplasms/*genetics
RNA/*metabolism
Algorithms ; Humans ; Neoplasms/pathology ; Oncogene Proteins, Fusion/genetics ; Oncogene Proteins, Fusion/metabolism ; RNA/genetics
Czasopismo naukowe
Tytuł:
Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases.
Autorzy:
Alhamar M; Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA.
Tudor Vladislav I; Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA.
Smith SC; Department of Pathology, Virginia Commonwealth University, Richmond, VA, USA.
Gao Y; Department of Pathology, Memorial University, St John's, Newfoundland, Canada.
Cheng L; Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA.
Favazza LA; Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA.
Alani AM; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.
Ittmann MM; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.
Riddle ND; Department of Pathology, USF Health, Ruffolo, Hooper, and Associates, Tampa, FL, USA.
Whiteley LJ; Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA.
Gupta NS; Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA.
Carskadon S; Department of Urology, Vattikutti Urology Institute, Henry Ford Health System, Detroit, MI, USA.
Gomez-Gelvez JC; Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA.
Chitale DA; Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA.; Department of Pathology, Wayne State University School of Medicine, Detroit, MI, USA.
Palanisamy N; Department of Urology, Vattikutti Urology Institute, Henry Ford Health System, Detroit, MI, USA.
Hes O; Department of Pathology, Charles University Faculty of Medicine, Plzen, Czech Republic.
Trpkov K; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Williamson SR; Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA.; Department of Pathology, Wayne State University School of Medicine, Detroit, MI, USA.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2020 Dec; Vol. 77 (6), pp. 890-899. Date of Electronic Publication: 2020 Sep 13.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Fusion*
Oncogene Proteins, Fusion/*genetics
Prostatic Neoplasms/*genetics
Aged ; Aged, 80 and over ; Carcinoma, Adenosquamous/genetics ; Carcinoma, Adenosquamous/pathology ; Carcinoma, Giant Cell/genetics ; Carcinoma, Giant Cell/pathology ; Carcinoma, Renal Cell/genetics ; Carcinoma, Renal Cell/pathology ; DNA-Binding Proteins/genetics ; DNA-Binding Proteins/metabolism ; Gene Rearrangement ; High-Throughput Nucleotide Sequencing ; Humans ; Immunohistochemistry ; In Situ Hybridization, Fluorescence ; Male ; Middle Aged ; Neoplasm Metastasis/genetics ; Neoplasm Metastasis/pathology ; Prostatic Neoplasms/pathology ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins B-raf/metabolism ; Serine Endopeptidases/genetics ; Transcription Factors/genetics ; Transcription Factors/metabolism ; Transcriptional Regulator ERG/genetics ; Transcriptional Regulator ERG/metabolism
Czasopismo naukowe
Tytuł:
Spindle Cell/Sclerosing Rhabdomyosarcoma With PAX8::PPARG Fusion.
Autorzy:
Rakheja D; Department of Pathology, 12334University of Texas Southwestern Medical Center, Dallas, TX, USA.; Children's Health, Dallas, TX, USA.
Park JY; Department of Pathology, 12334University of Texas Southwestern Medical Center, Dallas, TX, USA.; Children's Health, Dallas, TX, USA.
Alhasan M; Department of Radiology, 12334University of Texas Southwestern Medical Center, Dallas, TX, USA.; Children's Health, Dallas, TX, USA.
Uddin N; Department of Pathology, 12334University of Texas Southwestern Medical Center, Dallas, TX, USA.; Children's Health, Dallas, TX, USA.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2022 Dec; Vol. 30 (8), pp. 950-955. Date of Electronic Publication: 2022 Apr 24.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Rhabdomyosarcoma*/diagnosis
Rhabdomyosarcoma*/genetics
Rhabdomyosarcoma*/pathology
Rhabdomyosarcoma, Embryonal*/genetics
Male ; Humans ; Child, Preschool ; PPAR gamma/genetics ; Gene Fusion ; PAX8 Transcription Factor/genetics ; DNA-Binding Proteins/genetics ; Transcription Factors/genetics
Czasopismo naukowe
Tytuł:
Insights from a rare myeloproliferative neoplasm with coexisting BCR‐ABL1 fusion gene, CALR, and TET2 mutations treated with nilotinib and ruxolitinib.
Autorzy:
Huo, Li (AUTHOR)
Xie, Jundan (AUTHOR)
Wang, Qian (AUTHOR)
Shen, Hongjie (AUTHOR)
Ding, Zixuan (AUTHOR)
Wen, Lijun (AUTHOR)
Zeng, Zhao (AUTHOR)
Xu, Yi (AUTHOR)
Ruan, Changgeng (AUTHOR)
Chen, Suning (AUTHOR)
Xue, Mengxing (AUTHOR)
Pokaż więcej
Źródło:
Clinical Case Reports. Jan2023, Vol. 11 Issue 1, p1-7. 7p.
Czasopismo naukowe
Tytuł:
Partial response to pralsetinib in an advanced pulmonary sarcomatoid carcinoma patient harboring a KIF5B-RET rearrangement: a case report.
Autorzy:
Wu, Ying (AUTHOR)
Yan, Zhecheng (AUTHOR)
Pan, Juan (AUTHOR)
Chang, Xiaona (AUTHOR)
Huang, Bo (AUTHOR)
Luo, Danju (AUTHOR)
Meng, Rui (AUTHOR)
Shi, Heshui (AUTHOR)
Fan, Jun (AUTHOR)
Nie, Xiu (AUTHOR)
Pokaż więcej
Źródło:
World Journal of Surgical Oncology. 12/6/2022, Vol. 20 Issue 1, p1-5. 5p.
Czasopismo naukowe
Tytuł:
A short report of novel RARG-HNRNPM fusion gene in resembling acute promyelocytic leukemia.
Autorzy:
Song, Yang (AUTHOR)
Hou, Jiangxue (AUTHOR)
Wan, Li (AUTHOR)
Liu, Kaiqi (AUTHOR)
Zhou, Chunlin (AUTHOR)
Wei, Shuning (AUTHOR)
Zhang, Guangji (AUTHOR)
Lin, Dong (AUTHOR)
Li, Yan (AUTHOR)
Fang, Qiuyun (AUTHOR)
Liu, Yuntao (AUTHOR)
Gong, Benfa (AUTHOR)
Gong, Xiaoyuan (AUTHOR)
Wang, Ying (AUTHOR)
Wei, Hui (AUTHOR)
Wang, Jianxiang (AUTHOR)
Mi, Yingchang (AUTHOR)
Pokaż więcej
Źródło:
Hematology. Dec2022, Vol. 27 Issue 1, p518-522. 5p.
Czasopismo naukowe
Tytuł:
Vulvar angiomyofibroblastoma is molecularly defined by recurrent MTG1‐CYP2E1 fusions.
Autorzy:
Boyraz, Baris (AUTHOR)
Tajiri, Ryosuke (AUTHOR)
Alwaqfi, Rofieda R (AUTHOR)
Paula, Arnaud Da Cruz (AUTHOR)
Ye, Qiqi (AUTHOR)
Nielsen, G. Petur (AUTHOR)
Hung, Yin P (AUTHOR)
Oliva, Esther (AUTHOR)
Weigelt, Britta (AUTHOR)
Hisaoka, Masanori (AUTHOR)
Watkins, Jaclyn C (AUTHOR)
Pokaż więcej
Źródło:
Histopathology. Dec2022, Vol. 81 Issue 6, p841-846. 6p.
Czasopismo naukowe
Tytuł:
Transcriptome and Gene Fusion Analysis of Synchronous Lesions Reveals lncMRPS31P5 as a Novel Transcript Involved in Colorectal Cancer.
Autorzy:
Panza A; Division of Gastroenterology, IRCCS, Fondazione Casa Sollievo della Sofferenza, viale Cappuccini 1, 71013 San Giovanni Rotondo, Italy.
Castellana S; Unit of Bioinformatics, Fondazione IRCCS-Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.
Biscaglia G; Division of Gastroenterology, IRCCS, Fondazione Casa Sollievo della Sofferenza, viale Cappuccini 1, 71013 San Giovanni Rotondo, Italy.
Piepoli A; Division of Gastroenterology, IRCCS, Fondazione Casa Sollievo della Sofferenza, viale Cappuccini 1, 71013 San Giovanni Rotondo, Italy.
Parca L; Unit of Bioinformatics, Fondazione IRCCS-Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.
Gentile A; Division of Gastroenterology, IRCCS, Fondazione Casa Sollievo della Sofferenza, viale Cappuccini 1, 71013 San Giovanni Rotondo, Italy.
Latiano A; Division of Gastroenterology, IRCCS, Fondazione Casa Sollievo della Sofferenza, viale Cappuccini 1, 71013 San Giovanni Rotondo, Italy.
Mazza T; Unit of Bioinformatics, Fondazione IRCCS-Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.
Perri F; Division of Gastroenterology, IRCCS, Fondazione Casa Sollievo della Sofferenza, viale Cappuccini 1, 71013 San Giovanni Rotondo, Italy.
Andriulli A; Division of Gastroenterology, IRCCS, Fondazione Casa Sollievo della Sofferenza, viale Cappuccini 1, 71013 San Giovanni Rotondo, Italy.
Palmieri O; Division of Gastroenterology, IRCCS, Fondazione Casa Sollievo della Sofferenza, viale Cappuccini 1, 71013 San Giovanni Rotondo, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2020 Sep 27; Vol. 21 (19). Date of Electronic Publication: 2020 Sep 27.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Fusion*
Transcriptome*
Autoantigens/*genetics
Cell Cycle Proteins/*genetics
Colorectal Neoplasms/*genetics
Neoplasms, Multiple Primary/*genetics
RNA, Long Noncoding/*genetics
Ribosomal Proteins/*genetics
Transcription, Genetic/*genetics
Aged ; Biomarkers, Tumor/genetics ; Colorectal Neoplasms/pathology ; Female ; Gene Expression Regulation, Neoplastic ; Gene Regulatory Networks ; Humans ; Male ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Middle Aged ; RNA, Long Noncoding/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; RNA-Seq ; Reverse Transcriptase Polymerase Chain Reaction
Czasopismo naukowe
Tytuł:
DNA damage response and preleukemic fusion genes induced by ionizing radiation in umbilical cord blood hematopoietic stem cells.
Autorzy:
Kosik P; Deparment of Radiobiology, Biomedical Research Center, Cancer Research Institute, Slovak Academy of Sciences, Dubravska cesta 9, 845 05, Bratislava, Slovakia. .
Durdik M; Deparment of Radiobiology, Biomedical Research Center, Cancer Research Institute, Slovak Academy of Sciences, Dubravska cesta 9, 845 05, Bratislava, Slovakia.
Jakl L; Deparment of Radiobiology, Biomedical Research Center, Cancer Research Institute, Slovak Academy of Sciences, Dubravska cesta 9, 845 05, Bratislava, Slovakia.
Skorvaga M; Deparment of Radiobiology, Biomedical Research Center, Cancer Research Institute, Slovak Academy of Sciences, Dubravska cesta 9, 845 05, Bratislava, Slovakia.
Markova E; Deparment of Radiobiology, Biomedical Research Center, Cancer Research Institute, Slovak Academy of Sciences, Dubravska cesta 9, 845 05, Bratislava, Slovakia.
Vesela G; Deparment of Radiobiology, Biomedical Research Center, Cancer Research Institute, Slovak Academy of Sciences, Dubravska cesta 9, 845 05, Bratislava, Slovakia.
Vokalova L; Deparment of Radiobiology, Biomedical Research Center, Cancer Research Institute, Slovak Academy of Sciences, Dubravska cesta 9, 845 05, Bratislava, Slovakia.
Kolariková L; Deparment of Radiobiology, Biomedical Research Center, Cancer Research Institute, Slovak Academy of Sciences, Dubravska cesta 9, 845 05, Bratislava, Slovakia.
Horvathova E; Deparment of Genetics, Biomedical Research Center, Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic.
Kozics K; Deparment of Genetics, Biomedical Research Center, Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic.
Belyaev I; Deparment of Radiobiology, Biomedical Research Center, Cancer Research Institute, Slovak Academy of Sciences, Dubravska cesta 9, 845 05, Bratislava, Slovakia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Aug 24; Vol. 10 (1), pp. 13722. Date of Electronic Publication: 2020 Aug 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
DNA Breaks, Double-Stranded/*radiation effects
Fetal Blood/*radiation effects
Gene Fusion/*radiation effects
Hematopoietic Stem Cells/*radiation effects
Leukemia/*genetics
Antigens, CD34/metabolism ; Apoptosis/radiation effects ; DNA Repair/genetics ; Fusion Proteins, bcr-abl/genetics ; Fusion Proteins, bcr-abl/radiation effects ; Gene Fusion/genetics ; Histones/genetics ; Histones/metabolism ; Humans ; Infant, Newborn ; Lymphocytes/radiation effects ; Preleukemia/genetics ; Radiation, Ionizing ; Tumor Suppressor p53-Binding Protein 1/genetics ; Tumor Suppressor p53-Binding Protein 1/metabolism
Czasopismo naukowe
Tytuł:
Coxal giant cell‐rich tumour harbouring an NUTM1 gene fusion: a new molecular subtype of giant cell tumour of bone?
Autorzy:
Fattori, Antonin (AUTHOR)
Reita, Damien (AUTHOR)
Brinkert, David (AUTHOR)
Willaume, Thibault (AUTHOR)
Gantzer, Justine (AUTHOR)
Karanian, Marie (AUTHOR)
Lhermitte, Benoit (AUTHOR)
Wolf, Thibaut (AUTHOR)
De Pinieux, Gonzague (AUTHOR)
Weingertner, Noëlle (AUTHOR)
Pokaż więcej
Źródło:
Histopathology. May2024, Vol. 84 Issue 6, p1072-1075. 4p.
Czasopismo naukowe
Tytuł:
NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target.
Autorzy:
Gambella A; Pathology Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Senetta R; Pathology Unit, Department of Oncology, University of Turin, 10126 Turin, Italy.
Collemi G; Pathology Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Vallero SG; Pediatric Onco-Hematology Unit, Department of Pediatric and Public Health Sciences, University of Turin, 10126 Turin, Italy.
Monticelli M; Neurosurgery Unit, Department of Neurosciences, University of Turin, 10126 Turin, Italy.
Cofano F; Neurosurgery Unit, Department of Neurosciences, University of Turin, 10126 Turin, Italy.
Zeppa P; Neurosurgery Unit, Department of Neurosciences, University of Turin, 10126 Turin, Italy.
Garbossa D; Neurosurgery Unit, Department of Neurosciences, University of Turin, 10126 Turin, Italy.
Pellerino A; Department of Neuro-Oncology, University and City of Health and Science Hospital, 10126 Turin, Italy.
Rudà R; Department of Neuro-Oncology, University and City of Health and Science Hospital, 10126 Turin, Italy.
Soffietti R; Department of Neuro-Oncology, University and City of Health and Science Hospital, 10126 Turin, Italy.
Fagioli F; Pediatric Onco-Hematology Unit, Department of Pediatric and Public Health Sciences, University of Turin, 10126 Turin, Italy.
Papotti M; Pathology Unit, Department of Oncology, University of Turin, 10126 Turin, Italy.
Cassoni P; Pathology Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Bertero L; Pathology Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2020 Jan 23; Vol. 21 (3). Date of Electronic Publication: 2020 Jan 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Gene Fusion*
Central Nervous System Neoplasms/*genetics
Central Nervous System Neoplasms/*metabolism
Membrane Glycoproteins/*genetics
Protein Kinase Inhibitors/*therapeutic use
Receptor, trkA/*genetics
Receptor, trkB/*genetics
Receptor, trkC/*genetics
Animals ; Biomarkers, Tumor/genetics ; Central Nervous System Neoplasms/diagnosis ; Central Nervous System Neoplasms/drug therapy ; Humans ; Membrane Glycoproteins/metabolism ; Precision Medicine ; Receptor, trkA/metabolism ; Receptor, trkB/metabolism ; Receptor, trkC/metabolism ; Signal Transduction/genetics
Czasopismo naukowe
Tytuł:
Clear cell stromal tumor of the lung with multinucleated giant cells: a report of a case with YAP1-TFE3 fusion.
Autorzy:
Jakša R; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, 128 00, Prague 2, Czech Republic.
Stružinská I; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, 128 00, Prague 2, Czech Republic.
Kendall Bártů M; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, 128 00, Prague 2, Czech Republic.
Trča S; Department of Abdominal, Thoracic Surgery and Traumatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 00, Prague 2, Czech Republic.
Matěj R; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, 128 00, Prague 2, Czech Republic.; Department of Pathology, Charles University, 3rd Faculty of Medicine, University Hospital Kralovske Vinohrady, Prague, Czech Republic.; Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University, Thomayer Hospital, Prague, Czech Republic.
Dundr P; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, 128 00, Prague 2, Czech Republic. .
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2023 Jan 27; Vol. 18 (1), pp. 9. Date of Electronic Publication: 2023 Jan 27.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors*/genetics
Lung Neoplasms*/genetics
Male ; Humans ; Middle Aged ; Lung ; Gene Fusion ; Giant Cells/chemistry ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/analysis
Czasopismo naukowe
Tytuł:
Recent advances in cancer fusion transcript detection.
Autorzy:
Dorney R; epartment of Molecular & Cell Biology, College of Public Health, Medical & Vet Sciences, James Cook University, Douglas, QLD 4811, Australia.; Centre for Tropical Bioinformatics and Molecular Biology, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns 4878, Australia.
Dhungel BP; Gene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.; Faculty of Medicine & Health, The University of Sydney, Camperdown, NSW 2006, Australia.; Centre for Tropical Bioinformatics and Molecular Biology, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns 4878, Australia.
Rasko JEJ; Gene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.; Faculty of Medicine & Health, The University of Sydney, Camperdown, NSW 2006, Australia.
Hebbard L; epartment of Molecular & Cell Biology, College of Public Health, Medical & Vet Sciences, James Cook University, Douglas, QLD 4811, Australia.; Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Sydney, New South Wales, Australia.
Schmitz U; epartment of Molecular & Cell Biology, College of Public Health, Medical & Vet Sciences, James Cook University, Douglas, QLD 4811, Australia.; Centre for Tropical Bioinformatics and Molecular Biology, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns 4878, Australia.
Pokaż więcej
Źródło:
Briefings in bioinformatics [Brief Bioinform] 2023 Jan 19; Vol. 24 (1).
Typ publikacji:
Review; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplasms*/genetics
Humans ; Computational Biology ; Gene Fusion ; RNA/genetics
Czasopismo naukowe
Tytuł:
Cell block-based RNA next generation sequencing for detection of gene fusions in lung adenocarcinoma: An institutional experience.
Autorzy:
Wei S; Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Talarchek JN; Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Huang M; Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Gong Y; Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Du F; Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Ehya H; Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Flieder DB; Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Patchefsky AS; Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Wasik MA; Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Pei J; Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło:
Cytopathology : official journal of the British Society for Clinical Cytology [Cytopathology] 2023 Jan; Vol. 34 (1), pp. 28-34. Date of Electronic Publication: 2022 Sep 22.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/diagnosis
Adenocarcinoma*/genetics
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/diagnosis
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Humans ; High-Throughput Nucleotide Sequencing/methods ; Anaplastic Lymphoma Kinase/genetics ; Protein-Tyrosine Kinases/genetics ; Receptor Protein-Tyrosine Kinases/genetics ; RNA ; Retrospective Studies ; Proto-Oncogene Proteins/genetics ; Gene Fusion ; Oncogene Proteins, Fusion/genetics
Czasopismo naukowe
Tytuł:
A rare case of spindle cell neoplasm with NTRK-fusion in central nervous system.
Autorzy:
Gong H; Department of Pathology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Gao K; Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Mao P; Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Ma S; Department of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Zhao D; Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Bian Y; Department of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Liu R; Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Gao L; Department of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Duan Q; The Medical Department, Jiangsu Simcere Diagnostics Co. Ltd, Nanjing, Jiangsu Province, China.; Nanjing Simcere Medical Laboratory Science Co. Ltd., The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co. Ltd., Nanjing, Jiangsu Province, China.
Zhang Q; The Medical Department, Jiangsu Simcere Diagnostics Co. Ltd, Nanjing, Jiangsu Province, China.; Nanjing Simcere Medical Laboratory Science Co. Ltd., The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co. Ltd., Nanjing, Jiangsu Province, China.
Tan Y; The Medical Department, Jiangsu Simcere Diagnostics Co. Ltd, Nanjing, Jiangsu Province, China.; Nanjing Simcere Medical Laboratory Science Co. Ltd., The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co. Ltd., Nanjing, Jiangsu Province, China.
Wang T; Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Pokaż więcej
Źródło:
Pathology international [Pathol Int] 2023 Jan; Vol. 73 (1), pp. 52-54. Date of Electronic Publication: 2022 Jul 28.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Neoplasms*
Humans ; Receptor, trkA/genetics ; Central Nervous System ; Oncogene Proteins, Fusion/genetics ; Gene Fusion
Raport
Tytuł:
Myeloid neoplasm with ETV6::ACSl6 fusion: landscape of molecular and clinical features.
Autorzy:
Su Z; Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
Liu X; Department of Stem Cell Transplantation, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Hu W; Department of Hepatobiliary Surgery, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
Yang J; Department of Hematology Diagnosis Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
Yin X; Department of Hematology Diagnosis Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
Hou F; Department of Hematology Diagnosis Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
Wang Y; Department of Hematology Diagnosis Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
Zhang J; Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2022 Dec; Vol. 27 (1), pp. 1010-1018.
Typ publikacji:
Case Reports; Journal Article; Review
MeSH Terms:
Hypereosinophilic Syndrome*
Leukemia, Myeloid, Acute*/genetics
Myeloproliferative Disorders*/genetics
Myeloproliferative Disorders*/pathology
Chromosome Aberrations ; Gene Fusion ; Humans ; Leukemia ; Receptor, Platelet-Derived Growth Factor beta/genetics
SCR Disease Name:
Pdgfra-Associated Chronic Eosinophilic Leukemia
Czasopismo naukowe
Tytuł:
AML with inv(16)/t(16;16) and high-risk cytogenetic abnormalities: atypical features and unfavorable outcome.
Autorzy:
Assaf N; Department of Pathology and Laboratory Medicine, Cytogenetics division, American University of Beirut Medical Center, Beirut, Lebanon.
Lefebvre C; Laboratoire d'Hématologie Biologique, Centre Hospitalier Universitaire de Grenoble Alpes (CHUGA), La Tronche, France.
Raggueneau V; Department of Laboratory Medicine, Hematology, Centre Hospitalier de Versailles, Le Chesnay, France.
Guignedoux G; Laboratoire d'Hématologie, Centre Hospitalier René Dubos Pontoise, Pontoise, France.
Marceau-Renaut A; University of Lille, CNRS, Inserm, CHU Lille, Institut de Recherche contre le Cancer de Lille, UMR9020-UMR-S 1277-Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.
Chevalier S; Laboratoire d'Hématologie Biologique, Centre Hospitalier Universitaire de Grenoble Alpes (CHUGA), La Tronche, France.
Tondeur S; Laboratoire d'Hématologie Biologique, Centre Hospitalier Universitaire de Grenoble Alpes (CHUGA), La Tronche, France.
Bories D; Department of Molecular Onco-Hematology Henri Mondor Hospital (APHP-UPEC), Créteil, France.
Benramdane R; Laboratoire d'Hématologie, Centre Hospitalier René Dubos Pontoise, Pontoise, France.
Rousselot P; Department of Hematology, Centre Hospitalier de Versailles, France & University Paris-Saclay, UMR1184, Le Chesnay, France.
Terré C; Department of Laboratory Medicine, Hemato-Oncologic Cytogenetics, Centre Hospitalier de Versailles, Le Chesnay, France.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2022 Dec; Vol. 27 (1), pp. 636-641.
Typ publikacji:
Journal Article
MeSH Terms:
Chromosome Inversion*
Leukemia, Myeloid, Acute*/diagnosis
Aged ; Female ; Gene Fusion ; Gene Rearrangement ; Humans ; Oncogene Proteins, Fusion/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies